2ocd:D   (ASP127) to   (SER190)  CRYSTAL STRUCTURE OF L-ASPARAGINASE I FROM VIBRIO CHOLERAE O1 BIOVAR ELTOR STR. N16961  |   L-ASPARAGINASE I, SAD, MCSG, PSI-2, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, HYDROLASE 
1a81:C    (THR21) to    (ILE76)  CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM  |   COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX 
1a81:E    (THR21) to    (ILE76)  CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM  |   COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX 
1a81:G    (THR21) to    (ILE76)  CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM  |   COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX 
1a81:I    (THR21) to    (ILE76)  CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM  |   COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX 
1a81:K    (THR21) to    (ILE76)  CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM  |   COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX 
4gwf:A    (THR12) to    (TYR66)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION  |   ALPHA/BETA PROTEINS, SH2 DOMAIN, PHOSPHATASE DOMAIN, TYROSINE PHOSPHATASE SHP-2, HYDROLASE 
4gwf:B    (THR12) to    (TYR66)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION  |   ALPHA/BETA PROTEINS, SH2 DOMAIN, PHOSPHATASE DOMAIN, TYROSINE PHOSPHATASE SHP-2, HYDROLASE 
2aoa:B    (ALA68) to   (LEU120)  CRYSTAL STRUCTURES OF A HIGH-AFFINITY MACROCYCLIC PEPTIDE MIMETIC IN COMPLEX WITH THE GRB2 SH2 DOMAIN  |   GRB2 SH2, DOMAIN-SWAPPED, PEPTIDE MIMETIC, TRANSFERASE 
2aob:B    (ARG67) to   (LEU120)  CRYSTAL STRUCTURES OF A HIGH-AFFINITY MACROCYCLIC PEPTIDE MIMETIC IN COMPLEX WITH THE GRB2 SH2 DOMAIN  |   GRB2 SH2, PEPTIDE MIMETIC, DOMAIN SWAPPING, KINASE SIGNALLING, TRANSFERASE 
2aob:D    (PRO66) to   (LEU120)  CRYSTAL STRUCTURES OF A HIGH-AFFINITY MACROCYCLIC PEPTIDE MIMETIC IN COMPLEX WITH THE GRB2 SH2 DOMAIN  |   GRB2 SH2, PEPTIDE MIMETIC, DOMAIN SWAPPING, KINASE SIGNALLING, TRANSFERASE 
3ecj:A    (LEU28) to    (ARG82)  STRUCTURE OF E323L MUTANT OF HOMOPROTOCATECHUATE 2,3-DIOXYGENASE FROM BREVIBACTERIUM FUSCUM AT 1.65A RESOLUTION  |   OXIDOREDUCTASE, OXYGENASE, EXTRADIOL, FEII, CRYSTAL PACKING, DIOXYGENASE 
3eck:A    (LEU28) to    (ARG82)  STRUCTURE OF E323L HOMOPROTOCATECHUATE 2,3-DIOXYGENASE FROM BREVIBACTERIUM FUSCUM IN COMPLEX WITH PUTATIVE O-O BOND CLEAVAGE INTERMEDIATE FORMED VIA IN CRYSTALLO REACTION WITH 4-SULFONYL CATECHOL AT LOW OXYGEN CONCENTRATIONS  |   OXIDOREDUCTASE, OXYGENASE, EXTRADIOL, FEII, CRYSTAL PACKING, DIOXYGENASE 
1ad5:A   (SER154) to   (ILE214)  SRC FAMILY KINASE HCK-AMP-PNP COMPLEX  |   TYROSINE-PROTEIN KINASE, TRANSFERASE, SIGNAL TRANSDUCTION, SH2, SH3, PHOSPHORYLATION 
1ad5:B   (SER154) to   (TYR213)  SRC FAMILY KINASE HCK-AMP-PNP COMPLEX  |   TYROSINE-PROTEIN KINASE, TRANSFERASE, SIGNAL TRANSDUCTION, SH2, SH3, PHOSPHORYLATION 
3efs:A    (LEU69) to   (ASN123)  BIOTIN PROTEIN LIGASE FROM AQUIFEX AEOLICUS IN COMPLEX WITH BIOTIN AND ATP  |   BPL ATP BIOTIN COMPLEX, LIGASE 
1nnw:B   (MET162) to   (VAL210)  HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU-1218608  |   HYPOTHETICAL PROTEIN, PYROCOCCUS FURIOSUS, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, SOUTHEAST COLLABORATORY FOR STRUCTURAL GENOMICS, SECSG, UNKNOWN FUNCTION 
1aot:F    (GLY13) to    (ILE73)  NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, MINIMIZED AVERAGE STRUCTURE  |   SH2 DOMAIN, SIGNAL TRANSDUCTION, PEPTIDE COMPLEX, COMPLEX (PROTO-ONCOGENE/EARLY PROTEIN) 
1nrv:A   (SER441) to   (LEU499)  CRYSTAL STRUCTURE OF THE SH2 DOMAIN OF GRB10  |   DIMER, SIGNALING PROTEIN 
3elg:A    (VAL33) to    (CYS86)  CRYSTAL STRUCTURE OF A PUTATIVE PERIPLASMIC PROTEIN OF UNKNOWN FUNCTION (BVU_2443) FROM BACTEROIDES VULGATUS ATCC 8482 AT 1.64 A RESOLUTION  |   BLIP-LIKE FOLD, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, MEMBRANE PROTEIN 
4wuc:A   (GLY221) to   (ASP277)  N-TERMINAL 43 KDA FRAGMENT OF THE E. COLI DNA GYRASE B SUBUNIT GROWN FROM 100 MM NACL CONDITION  |   DNA GYRASE, ATPASE DOMAIN, ATPASE ACTIVITY, GHKL SUPERFAMILY, MONOVALENT CATIONS, ISOMERASE 
2p2d:A   (GLU123) to   (ASN191)  CRYSTAL STRUCTURE AND ALLOSTERIC REGULATION OF THE CYTOPLASMIC ESCHERICHIA COLI L-ASPARAGINASE I  |   ASPARAGINASE, TRANSFERASE 
2p2d:D   (GLU123) to   (LEU190)  CRYSTAL STRUCTURE AND ALLOSTERIC REGULATION OF THE CYTOPLASMIC ESCHERICHIA COLI L-ASPARAGINASE I  |   ASPARAGINASE, TRANSFERASE 
1nzv:A   (THR156) to   (ILE216)  CRYSTAL STRUCTURE OF SRC SH2 DOMAIN BOUND TO DOUBLY PHOSPHORYLATED PEPTIDE PQPYIPYVPA  |   SH2 DOMAIN, PHOSPHOTYROSINE, TRANSFERASE 
2p2n:D   (GLY128) to   (ASN191)  CRYSTAL STRUCTURE AND ALLOSTERIC REGULATION OF THE CYTOPLASMIC ESCHERICHIA COLI L-ASPARAGINASE I  |   ASPARAGINASE, TRANSFERASE 
3esw:A   (GLY192) to   (ASP242)  COMPLEX OF YEAST PNGASE WITH GLCNAC2-IAC.  |   GLYCOPROTEINS PEPTIDE:N-GLYCANASE CHITOBIOSE, HYDROLASE, METAL- BINDING, NUCLEUS, DNA DAMAGE, DNA REPAIR, PHOSPHOPROTEIN, UBL CONJUGATION PATHWAY 
3f1v:B     (GLU6) to    (PRO65)  E. COLI BETA SLIDING CLAMP, 148-153 ALA MUTANT  |   PROTEIN, DNA REPLICATION, DNA-DIRECTED DNA POLYMERASE, NUCLEOTIDYLTRANSFERASE, TRANSFERASE 
1o41:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78300.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o42:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU81843.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o43:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82129.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o44:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85052  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o45:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU84687.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o46:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU90395.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o48:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85053.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o47:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82209.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4a:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82197.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4c:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4g:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH DPI59.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4i:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PAS219.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4j:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH ISO24.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4k:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PASBN.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4l:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH FRAGMENT2.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4m:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH MALONICACID.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4n:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH OXALIC ACID.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4o:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHENYLPHOSPHATE.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4p:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78791.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4r:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78783.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1bmb:A    (PRO66) to   (LEU120)  GRB2-SH2 DOMAIN IN COMPLEX WITH KPFY*VNVEF (PKF270-974)  |   SH2 DOMAIN, SIGNAL TRANSDUCTION, ADAPTOR PROTEIN, RAS PATHWAY, HORMONE/GROWTH FACTOR COMPLEX 
4x6s:B   (SER437) to   (MET495)  GRB7 SH2 DOMAIN WITH PHOSPHOTYROSINE MIMETIC INHIBITOR PEPTIDE  |   SRC HOMOLOGY DOMAIN, INHIBITOR, PHOSPHOTYROSINE BINDING POCKET, SIGNALING PROTEIN-INHIBITOR COMPLEX 
1oa2:A    (LEU21) to    (THR72)  COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY  |   HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, ENDOGLUCANASE, GLYCOSYL HYDROLASE, GH FAMILY 12, TRICHODERMA REESEI CEL12A 
1oa3:C    (LEU21) to    (THR72)  COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY  |   HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, ENDOGLUCANASE, GLYCOSYL HYDROLASE, GH FAMILY 12, HYPOCREA SCHWEINITZII CEL12A 
1oa3:D    (LEU21) to    (THR72)  COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY  |   HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, ENDOGLUCANASE, GLYCOSYL HYDROLASE, GH FAMILY 12, HYPOCREA SCHWEINITZII CEL12A 
3s9k:A    (SER17) to    (VAL78)  CRYSTAL STRUCTURE OF THE ITK SH2 DOMAIN.  |   PROLINE ISOMERIZATION, CIS PROLINE, DOMAIN SWAPPED DIMER, SH2 DOMAIN, TRANSFERASE 
1bxo:A   (ASP222) to   (PRO268)  ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL CYCLO[(2S)-2-[[(1R)-1-(N-(L-N-(3- METHYLBUTANOYL)VALYL-L-ASPARTYL)AMINO)-3-METHYLBUT YL] HYDROXYPHOSPHINYLOXY]-3-(3-AMINOMETHYL) PHENYLPROPANOATE  |   HYDROLASE, PHOSPHONATE INHIBITORS, MACROCYCLE 
2pld:A    (THR17) to    (GLY70)  NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE  |   PHOSPHORIC DIESTER HYDROLASE 
4xdr:A   (LYS165) to   (SER231)  CRYSTAL STRUCTURE OF TREPONEMA PALLIDUM TP0796 FLAVIN TRAFFICKING PROTEIN, A BIFUNCTIONAL FMN TRANSFERASE/FAD PYROPHOSPHATASE, D284A MUTANT, ADN BOUND FORM  |   FMN TRANSFERASE, FAD PYROPHOSPHATASE, HYDROLASE, BIMETAL CENTER, FLAVIN TURNOVER, TREPONEMA PALLIDUM, TRANSFERASE 
1c54:A    (PRO12) to    (LEU91)  SOLUTION STRUCTURE OF RIBONUCLEASE SA  |   ALPHA+BETA PROTEIN, HYDROLASE 
4xgv:A   (LEU164) to   (ASP227)  CRYSTAL STRUCTURE OF ESCHERICHIA COLI FLAVIN TRAFFICKING PROTEIN, AN FMN TRANSFERASE  |   FLAVIN TRANSFERASE, BIMETAL CENTER, LIPOPROTEIN, TRANSFERASE 
1chd:A   (PHE195) to   (LEU236)  CHEB METHYLESTERASE DOMAIN  |   CHEMOTAXIS PROTEIN, SERINE HYDROLASE, CARBOXYL METHYLESTERASE 
1cj1:A    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:B    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:C    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:D    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:E    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:F    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:G    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:H    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:I    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:J    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:K    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
1cj1:L    (ARG67) to   (LEU120)  GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE  |   SIGNAL TRANSDUCTION, SH2 DOMAIN, PHOSPHOTYROSINE, SIGNALING PROTEIN 
4ihq:C   (ASN168) to   (SER225)  ARCHAELLUM ASSEMBLY ATPASE FLAI BOUND TO ADP  |   HEXAMER, HYDROLASE, ATP/ADP, MEMBRANE ASSOCIATED 
3t04:A   (SER152) to   (VAL205)  CRYSTAL STRUCTURE OF MONOBODY 7C12/ABL1 SH2 DOMAIN COMPLEX  |   ENGINEERED BINDING PROTEIN, ANTIBODY MIMIC, PROTEIN-PROTEIN COMPLEX, SH2 DOMAIN, ATP-BINDING, PHOSPHOPROTEIN, TYROSINE-PROTEIN KINASE, SIGNALING PROTEIN-PROTEIN BINDING COMPLEX 
4ipb:A    (GLY26) to    (ASP78)  CRYSTAL STRUCTURE OF A DUF2874 FAMILY PROTEIN (BACOVA_02504) FROM BACTEROIDES OVATUS ATCC 8483 AT 1.62 A RESOLUTION  |   PF11396 FAMILY PROTEIN, DUF2874, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, UNKNOWN FUNCTION 
2qms:C   (SER437) to   (MET495)  CRYSTAL STRUCTURE OF A SIGNALING MOLECULE  |   SH2 DOMAIN, ALPHA/BETA FOLD, SIGNALING PROTEIN 
2qms:D   (SER437) to   (MET495)  CRYSTAL STRUCTURE OF A SIGNALING MOLECULE  |   SH2 DOMAIN, ALPHA/BETA FOLD, SIGNALING PROTEIN 
3gmu:B    (ARG97) to   (ASP163)  CRYSTAL STRUCTURE OF BETA-LACTAMSE INHIBITORY PROTEIN (BLIP) IN APO FORM  |   2-LAYER ALPHA/BETA SANDWICH, DISULFIDE BOND, SECRETED, PROTEIN BINDING 
4y35:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 290  |   FAGMENT SCREENING, HYDROLASE, INHIBITION 
4y37:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGEMENT 305  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3a:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 181  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3h:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 189  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3r:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 306  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3s:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 266  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
2qzb:A    (GLU57) to   (LEU110)  CRYSTAL STRUCTURE OF THE UNCHARACTERIZED PROTEIN YFEY FROM ESCHERICHIA COLI  |   STRUCTURAL GENOMICS, UNKNOWN FUNCTION, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC 
2qzb:B    (GLU57) to   (LEU110)  CRYSTAL STRUCTURE OF THE UNCHARACTERIZED PROTEIN YFEY FROM ESCHERICHIA COLI  |   STRUCTURAL GENOMICS, UNKNOWN FUNCTION, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC 
4y3w:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 35  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3x:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 171  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y47:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 162  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4a:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 286  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4c:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 158  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4d:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B51  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y4j:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B97  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y4t:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 114  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4z:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 73  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y53:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 54  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y54:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 56  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
3gqi:B   (THR674) to   (LEU726)  CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES  |   PHOSPHORYLATED KINASE, PY-RECOGNITION, TANDEM SH2 DOMAINS, ATP ANALOG, ATP-BINDING, CRANIOSYNOSTOSIS, DISEASE MUTATION, DISULFIDE BOND, DWARFISM, GLYCOPROTEIN, HEPARIN-BINDING, HYPOGONADOTROPIC HYPOGONADISM, IMMUNOGLOBULIN DOMAIN, KALLMANN SYNDROME, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, HYDROLASE, LIPID DEGRADATION, SH2 DOMAIN, SH3 DOMAIN, TRANSDUCER, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
4y57:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 63  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y5a:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 206  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5b:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 261  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5c:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 267  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y5e:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 268  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5l:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN ITS APO FORM  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y5k:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 274  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5m:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 328  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y5n:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 337  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y5p:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 338  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
2r6u:C    (GLY15) to    (ASP76)  CRYSTAL STRUCTURE OF GENE PRODUCT RHA04853 FROM RHODOCOCCUS SP. RHA1  |   STRUCTURAL GENOMICS, PSI-2, RHA04853, MCSG, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, UNKNOWN FUNCTION 
2dm0:A    (THR24) to    (VAL83)  SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN TYROSINE- PROTEIN KINASE TXK  |   TEC FAMILY KINASE, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, TRANSFERASE 
4jgh:A    (VAL55) to   (LEU106)  STRUCTURE OF THE SOCS2-ELONGIN BC COMPLEX BOUND TO AN N-TERMINAL FRAGMENT OF CULLIN5  |   CULLIN-RING E3 UBIQUITIN LIGASES, UBIQUITINATION, CYTOSOL, LIGASE 
4yck:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 211  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yct:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 216  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yd3:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 224  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yd5:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 236  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yd6:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 240  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
2dx0:A   (SER539) to   (TYR600)  CRYSTAL STRUCTURE OF THE N-TERMINAL SH2 DOMAIN OF MOUSE PHOSPHOLIPASE C-GAMMA 2  |   PHOSPHORIC DIESTER HYDROLASE, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI 
2dx0:B   (SER542) to   (TYR600)  CRYSTAL STRUCTURE OF THE N-TERMINAL SH2 DOMAIN OF MOUSE PHOSPHOLIPASE C-GAMMA 2  |   PHOSPHORIC DIESTER HYDROLASE, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI 
1epl:E   (PRO224) to   (PRO269)  A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1er8:E   (THR226) to   (PRO269)  THE ACTIVE SITE OF ASPARTIC PROTEINASES  |   HYDROLASE, ACID PROTEINASE 
4jmg:A    (PRO46) to   (TRP101)  CRYSTAL STRUCTURE OF THE SYNTHETIC PROTEIN IN COMPLEX WITH PY PEPTIDE  |   SYNTHETIC PROTEIN, BINDING TO PHOSPHOTYROSINE CONTAINING SEQUENCE, DE NOVO PROTEIN 
4jmh:A    (PRO46) to   (GLY107)  CRYSTAL STRUCTURE OF SYNTHETIC PROTEIN IN COMPLEX WITH DOUBLE PY PEPTIDE  |   SYNTHETIC PROTEIN, BINDING TO DOUBLE PY CONTAINING SEQUENCE, DE NOVO PROTEIN 
1ewj:C    (ASP15) to    (ARG65)  CRYSTAL STRUCTURE OF BLEOMYCIN-BINDING PROTEIN COMPLEXED WITH BLEOMYCIN  |   BLEOMYCIN-BINDING PROTEIN, BLEOMYCIN, ANTIBIOTICS RESISTANCE, HOMODIMER, ANTIBIOTIC INHIBITOR 
1ewj:F    (PHE14) to    (ARG65)  CRYSTAL STRUCTURE OF BLEOMYCIN-BINDING PROTEIN COMPLEXED WITH BLEOMYCIN  |   BLEOMYCIN-BINDING PROTEIN, BLEOMYCIN, ANTIBIOTICS RESISTANCE, HOMODIMER, ANTIBIOTIC INHIBITOR 
2src:A   (THR154) to   (ILE214)  CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP  |   SRC, TYROSINE-PROTEIN KINASE, PHOSPHORYLATION, SH2, SH3, PHOSPHOTYROSINE, PROTO-ONCOGENE, PHOSPHOTRANSFERASE 
3u1w:A   (PRO164) to   (ALA217)  CRYSTAL STRUCTURE OF A CALCIUM BINDING PROTEIN (BDI_1975) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 2.00 A RESOLUTION  |   BLIP-LIKE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, METAL BINDING PROTEIN 
3u1w:B   (PRO164) to   (ALA217)  CRYSTAL STRUCTURE OF A CALCIUM BINDING PROTEIN (BDI_1975) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 2.00 A RESOLUTION  |   BLIP-LIKE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, METAL BINDING PROTEIN 
3u1w:C   (LYS165) to   (ALA217)  CRYSTAL STRUCTURE OF A CALCIUM BINDING PROTEIN (BDI_1975) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 2.00 A RESOLUTION  |   BLIP-LIKE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, METAL BINDING PROTEIN 
2ecd:A    (SER24) to    (VAL77)  SOLUTION STRUCTURE OF THE HUMAN ABL2 SH2 DOMAIN  |   SH2 DOMAIN, PHOSPHOTYROSINE BINDING DOMAIN, PROTEIN TYROSINE KINASE, SIGNAL TRANSDUCTION, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN 
1r1p:A    (SER66) to   (LEU119)  STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS  |   SH2, GADS, PHOSPHOPEPTIDE, PEPTIDE BINDING PROTEIN 
1r1p:B    (SER66) to   (LEU119)  STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS  |   SH2, GADS, PHOSPHOPEPTIDE, PEPTIDE BINDING PROTEIN 
1r1p:C    (SER66) to   (LEU119)  STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS  |   SH2, GADS, PHOSPHOPEPTIDE, PEPTIDE BINDING PROTEIN 
1r1p:D    (SER66) to   (LEU119)  STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS  |   SH2, GADS, PHOSPHOPEPTIDE, PEPTIDE BINDING PROTEIN 
4k11:A   (THR154) to   (ILE214)  THE STRUCTURE OF 1NA IN COMPLEX WITH SRC T338G  |   1NA, C-SRC, KINASE, PHOSPHORYLATION, TRANSFERASE 
3hhm:B   (SER339) to   (PHE392)  CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA AND THE DRUG WORTMANNIN  |   P110, P85, PI3KCA, PI3K, PIK3R1, PHOSPHATIDILYNOSITOL 3,4,5- TRIPHOSPHATE, WORTMANNIN, H1047R, ATP-BINDING, DISEASE MUTATION, KINASE, NUCLEOTIDE-BINDING, ONCOGENE, POLYMORPHISM, TRANSFERASE, TRANSFERASE/ONCOPROTEIN COMPLEX 
2er6:E   (PRO224) to   (PRO269)  THE STRUCTURE OF A SYNTHETIC PEPSIN INHIBITOR COMPLEXED WITH ENDOTHIAPEPSIN.  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE 
3hjh:A   (SER137) to   (VAL194)  A RIGID N-TERMINAL CLAMP RESTRAINS THE MOTOR DOMAINS OF THE BACTERIAL TRANSCRIPTION-REPAIR COUPLING FACTOR  |   MFD, MUTATION FREQUENCY DECLINE, TRANSCRIPTION-COUPLED DNA REPAIR, TRANSCRIPTION-REPAIR COUPLING FACTOR, ATP-BINDING, DNA DAMAGE, DNA REPAIR, DNA-BINDING, HELICASE, HYDROLASE, NUCLEOTIDE-BINDING 
2ewn:A   (ALA146) to   (ILE207)  ECOLI BIOTIN REPRESSOR WITH CO-REPRESSOR ANALOG  |   HELIX-TURN-HELIX, DISORDER-TO-ORDER TRANSITION, BIOTIN, LIGASE, TRANSCRIPTION 
2v7s:A   (ALA132) to   (GLY189)  CRYSTAL STRUCTURE OF THE PUTATIVE LIPOPROTEIN LPPA FROM MYCOBACTERIUM TUBERCULOSIS  |   LIPOPROTEIN, UNKNOWN FUNCTION, PUTATIVE LIPOPROTEIN 
4k74:A    (PRO71) to   (THR129)  THE UMUC SUBUNIT OF THE E. COLI DNA POLYMERASE V SHOWS A UNIQUE INTERACTION WITH THE BETA-CLAMP PROCESSIVITY FACTOR.  |   DNA REPLICATION CLAMP PROCESSIVITY FACTOR, DNA REPLICATION/REPAIR, DNA BINDING PROTEIN-TRANSFERASE COMPLEX 
2f4o:A   (ARG305) to   (ASP357)  THE MOUSE PNGASE-HR23 COMPLEX REVEALS A COMPLETE REMODULATION OF THE PROTEIN-PROTEIN INTERFACE COMPARED TO ITS YEAST ORTHOLOGS  |   GLYCOPROTEINS, UBIQUITIN-DEPENDENT PROTEIN DEGRADATION, NUCLEOTIDE EXCISION REPAIR, PEPTIDE:N-GLYCANASE, TRANSGLUTAMINASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1fyr:B    (PRO66) to   (LEU120)  DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTAL STRUCTURE OF THE GRB2-SH2 AC-PYVNV COMPLEX  |   GRB2, SH2 DOMAIN, PHOSPHOPEPTIDE, MET, DOMAIN SWAPPING, DIMERIZATION, HORMONE/GROWTH FACTOR COMPLEX 
2ffg:A     (SER2) to    (ASP65)  NOVEL X-RAY STRUCTURE OF THE YKUJ PROTEIN FROM BACILLUS SUBTILIS. NORTHEAST STRUCTURAL GENOMICS TARGET SR360.  |   X-RAY SR360 NESG YKUJ, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, UNKNOWN FUNCTION 
2ffg:B     (SER2) to    (ASP65)  NOVEL X-RAY STRUCTURE OF THE YKUJ PROTEIN FROM BACILLUS SUBTILIS. NORTHEAST STRUCTURAL GENOMICS TARGET SR360.  |   X-RAY SR360 NESG YKUJ, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, UNKNOWN FUNCTION 
3uri:A   (PRO227) to   (PRO273)  ENDOTHIAPEPSIN-DB5 COMPLEX.  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TRANSITION STATE ANALOGUE. 
3urj:A   (PRO227) to   (PRO273)  TYPE IV NATIVE ENDOTHIAPEPSIN  |   ASPARTIC PROTEINASE, PROTEOLYSIS, SECRETED., HYDROLASE 
4z4f:A   (PHE156) to   (ALA223)  HUMAN ARGONAUTE2 BOUND TO T1-DAP TARGET RNA  |   ARGONAUTE2, GENE REGULATION-RNA COMPLEX 
2vj0:A   (GLY700) to   (ASN751)  CRYSTAL STRUCTURE OF THE ALPHA-ADAPTIN APPENDAGE DOMAIN, FROM THE AP2 ADAPTOR COMPLEX, IN COMPLEX WITH AN FXDNF PEPTIDE FROM AMPHIPHYSIN1 AND A WVXF PEPTIDE FROM SYNAPTOJANIN P170  |   PROTEIN TRANSPORT, CYTOPLASMIC VESICLE, ALTERNATIVE SPLICING, TRANSPORT, COATED PIT, SH3 DOMAIN, ENDOCYTOSIS, ALPHA-ADAPTIN, GOLGI APPARATUS, PHOSPHORYLATION, AP2, SYNAPSE, MEMBRANE, CYTOPLASM, COILED COIL, AMPHIPHYSIN, CYTOSKELETON, SYNAPTOJANIN, LIPID-BINDING, CELL JUNCTION 
1s0w:C  (THR1096) to  (ASP1163)  1B LACTAMSE/ B LACTAMASE INHIBITOR  |   PROTEIN-PROTEIN COMPLEX, TEM-1 BETA-LACTAMASE, BETA- LACTAMASE INHIBITOR PROTEIN, BLIP, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, STRUCTURAL GENOMICS, HYDROLASE 
1s0w:D  (THR1096) to  (ASP1163)  1B LACTAMSE/ B LACTAMASE INHIBITOR  |   PROTEIN-PROTEIN COMPLEX, TEM-1 BETA-LACTAMASE, BETA- LACTAMASE INHIBITOR PROTEIN, BLIP, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, STRUCTURAL GENOMICS, HYDROLASE 
2fo0:A   (SER152) to   (VAL205)  ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORMS OF THE C-ABL TYROSINE KINASE  |   N-TERMINAL CAP, AUTOINHIBITION, MYRISTOYLATION, SH3-SH2 CLAMP, PHOSPHOSERINE, TRANSFERASE 
4zea:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B91  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
1sha:A    (THR11) to    (ILE71)  CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES  |   PHOSPHOTRANSFERASE 
2g2w:B    (THR96) to   (ASP163)  CRYSTAL STRUCTURE OF THE SHV D104K BETA-LACTAMASE/BETA-LACTAMASE INHIBITOR PROTEIN (BLIP) COMPLEX  |   BETA-LACTAMASE, BETA-LACTAMASE INHIBITOR, PROTEIN-PROTEIN COMPLEX, BLIP, SHV, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1skj:A    (THR11) to    (ILE71)  COCRYSTAL STRUCTURE OF UREA-SUBSTITUTED PHOSPHOPEPTIDE COMPLEX  |   TYROSINE-PROTEIN KINASE, V-SRC SH2 DOMAIN, PHOSPHOTYROSINE RECOGNITION DOMAIN, PP60 SRC SH2 DOMAIN, PEPTIDOMIMETIC, UREIDO 
1spr:A    (THR11) to    (ILE71)  BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS  |   TRANSFERASE(PHOSPHOTRANSFERASE) 
4l1b:B   (ARG340) to   (GLY391)  CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA  |   ATP BINDING, SIGNALING PROTEIN-TRANSFERASE-INHIBITOR COMPLEX 
2gia:A   (TYR130) to   (ASP198)  CRYSTAL STRUCTURES OF TRYPANOSOMA BRUCIEI MRP1/MRP2  |   T. BRUCEI; GUIDE RNA; MATCHMAKING; RNA EDITING, TRANSLATION 
2gia:B    (VAL91) to   (PHE146)  CRYSTAL STRUCTURES OF TRYPANOSOMA BRUCIEI MRP1/MRP2  |   T. BRUCEI; GUIDE RNA; MATCHMAKING; RNA EDITING, TRANSLATION 
2gia:G   (TYR130) to   (ASP198)  CRYSTAL STRUCTURES OF TRYPANOSOMA BRUCIEI MRP1/MRP2  |   T. BRUCEI; GUIDE RNA; MATCHMAKING; RNA EDITING, TRANSLATION 
2gid:G   (PRO127) to   (VAL199)  CRYSTAL STRUCTURES OF TRYPANOSOMA BRUCIEI MRP1/MRP2  |   T. BRUCEI; GUIDE RNA; MATCHMAKING; RNA EDITING, TRANSLATION 
2gid:H   (TYR130) to   (ASP198)  CRYSTAL STRUCTURES OF TRYPANOSOMA BRUCIEI MRP1/MRP2  |   T. BRUCEI; GUIDE RNA; MATCHMAKING; RNA EDITING, TRANSLATION 
2gid:P   (TYR130) to   (GLU196)  CRYSTAL STRUCTURES OF TRYPANOSOMA BRUCIEI MRP1/MRP2  |   T. BRUCEI; GUIDE RNA; MATCHMAKING; RNA EDITING, TRANSLATION 
4l23:B   (SER339) to   (GLY391)  CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND PI-103  |   ATP BINDING, PI-103, SIGNALING PROTEIN-TRANSFERASE-INHIBITOR COMPLEX 
4l2y:B   (ARG340) to   (GLY391)  CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND COMPOUND 9D  |   ATP BINDING, SIGNALING PROTEIN-TRANSFERASE-INHIBITOR COMPLEX 
1t3b:A     (ASP2) to    (GLY49)  X-RAY STRUCTURE OF DSBC FROM HAEMOPHILUS INFLUENZAE  |   OXIDOREDUCTASE, PROTEIN DISULFIDE ISOMERASE, PROTEIN FOLDING, REDOX PROTEIN, REDOX-ACTIVE CENTER 
4l6b:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH THIOPHEN-BASED INHIBITOR SAP128  |   ASPARTATE PROTEASE, INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lap:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH THIOPHEN-BASED INHIBITOR SAP114  |   ASPARTATE PROTEASE, INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1h8v:B    (LEU21) to    (THR72)  THE X-RAY CRYSTAL STRUCTURE OF THE TRICHODERMA REESEI FAMILY 12 ENDOGLUCANASE 3, CEL12A, AT 1.9 A RESOLUTION  |   HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, GH FAMILY 12, GLYCOSYL HYDROLASE 
1h8v:F    (LEU21) to    (THR72)  THE X-RAY CRYSTAL STRUCTURE OF THE TRICHODERMA REESEI FAMILY 12 ENDOGLUCANASE 3, CEL12A, AT 1.9 A RESOLUTION  |   HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, GH FAMILY 12, GLYCOSYL HYDROLASE 
3imj:A    (PRO66) to   (LEU120)  CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A CYCLOPROPYL-CONSTRAINED AC-PTYR-ILE-ASN-NH2 TRIPEPTIDE MIMIC  |   LIGAND PREORGANIZATION, PEPTIDE MIMICS, GOLGI APPARATUS, HOST-VIRUS INTERACTION, PHOSPHOPROTEIN, SH2 DOMAIN, SH3 DOMAIN, SIGNALING PROTEIN-PSEUDOPEPTIDE LIGAND COMPLEX, SIGNALING PROTEIN-PEPTIDE COMPLEX 
1tjd:A     (ASP1) to    (GLN48)  THE CRYSTAL STRUCTURE OF THE REDUCED DISULPHIDE BOND ISOMERASE, DSBC, FROM ESCHERICHIA COLI  |   DIMER, ISOMERASE 
2h46:E    (ARG67) to   (LEU120)  NATIVE DOMAIN-SWAPPED DIMER CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN  |   HELIX-SHEET-HELIX, HORMONE-GROWTH FACTOR COMPLEX 
4zxa:W    (PRO62) to   (ASN119)  CRYSTAL STRUCTURE OF HYDROQUINONE 1,2-DIOXYGENASE PNPCD IN COMPLEX WITH CD2+ AND 4-HYDROXYBENZONITRILE  |   DIOXYGENASE, HYDROQUINONE PATHWAY, CUPIN, OXIDOREDUCTASE 
4zxa:Z    (PRO62) to   (ASN119)  CRYSTAL STRUCTURE OF HYDROQUINONE 1,2-DIOXYGENASE PNPCD IN COMPLEX WITH CD2+ AND 4-HYDROXYBENZONITRILE  |   DIOXYGENASE, HYDROQUINONE PATHWAY, CUPIN, OXIDOREDUCTASE 
2hck:A   (SER154) to   (ILE214)  SRC FAMILY KINASE HCK-QUERCETIN COMPLEX  |   TRANSFERASE, PROTEIN TYROSINE KINASE, SIGNAL TRANSDUCTION, SH2, SH3 
2hck:B   (SER154) to   (ILE214)  SRC FAMILY KINASE HCK-QUERCETIN COMPLEX  |   TRANSFERASE, PROTEIN TYROSINE KINASE, SIGNAL TRANSDUCTION, SH2, SH3 
2hdv:B   (SER533) to   (GLN590)  CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF THE ADAPTER PROTEIN SH2-B  |   SH2, ADAPTER PROTEIN, SIGNALING PROTEIN 
3vs3:A   (SER155) to   (ILE215)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)- 7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
1hxd:A   (ALA146) to   (VAL202)  CRYSTAL STRUCTURE OF E. COLI BIOTIN REPRESSOR WITH BOUND BIOTIN  |   LIGASE, REPRESSOR, BIOTIN, DNA-BINDING 
1hxd:B   (ALA146) to   (ASN208)  CRYSTAL STRUCTURE OF E. COLI BIOTIN REPRESSOR WITH BOUND BIOTIN  |   LIGASE, REPRESSOR, BIOTIN, DNA-BINDING 
2hox:C     (LYS7) to    (GLY56)  ALLIINASE FROM ALLIUM SATIVUM (GARLIC)  |   CYSTEINE SULPHOXIDE LYASE, ALLIINASE, LYASE 
1i3z:A    (THR11) to    (ILE65)  MURINE EAT2 SH2 DOMAIN IN COMPLEX WITH SLAM PHOSPHOPEPTIDE  |   SH2 DOMAIN PHOSPHOTYROSINE SIGNAL TRANSDUCTION LYMPHOCYTE, SIGNALING PROTEIN 
4lud:A   (SER155) to   (ILE215)  CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002  |   COCRYSTALLIZATION, SKF86002, FLUORESCENCE, INHIBITOR SCREENING, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2huw:B    (PRO66) to   (LEU120)  X-RAY CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN COMPLEXED TO A CONSTRAINED AND CYCLOPROPANE-DERIVED LIGAND  |   CYLCOPROPANE, CONTRAINED, GRB2, SH2, PREORGANIZATION,, HORMONE/GROWTH FACTOR COMPLEX 
5a4x:B   (ILE119) to   (PRO189)  THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND ZN  |   LIPID BINDING PROTEIN, CALCIUM BINDING PROTEIN, C2 DOMAIN 
5a51:A   (LYS120) to   (PRO189)  THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND PHOPHATIDYL SERINE  |   LIPID BINDING PROTEIN, CALCIUM BINDING PROTEIN, C2 DOMAIN 
5a51:B   (LYS120) to   (PRO189)  THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND PHOPHATIDYL SERINE  |   LIPID BINDING PROTEIN, CALCIUM BINDING PROTEIN, C2 DOMAIN 
2i44:A   (LEU112) to   (PHE181)  CRYSTAL STRUCTURE OF SERINE-THREONINE PHOSPHATASE 2C FROM TOXOPLASMA GONDII  |   PHOSPHATASE, PSI-2, 8817Z, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, HYDROLASE 
2i44:C   (PRO104) to   (PHE181)  CRYSTAL STRUCTURE OF SERINE-THREONINE PHOSPHATASE 2C FROM TOXOPLASMA GONDII  |   PHOSPHATASE, PSI-2, 8817Z, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, HYDROLASE 
2i8d:A    (THR13) to    (GLU67)  CRYSTAL STRUCTURE OF AN UNCHARACTERIZED CONSERVED PROTEIN OF COG5646 (ZP_00384875.1) FROM LACTOBACILLUS CASEI ATCC 334 AT 1.69 A RESOLUTION  |   ZP_00384875.1, UNCHARACTERIZED CONSERVED PROTEIN OF COG5646, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, STRUCTURAL GENOMICS-UNKNOWN FUNCTION COMPLEX 
2it9:A    (ASP34) to   (PRO106)  CRYSTAL STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION FROM DUF155 FAMILY (YP_292156.1) FROM PROCHLOROCOCCUS SP. NATL2A AT 1.80 A RESOLUTION  |   YP_292156.1, HYPOTHETICAL PROTEIN, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, STRUCTURAL GENOMICS-UNKNOWN FUNCTION COMPLEX 
2it9:D    (ASP34) to   (PRO106)  CRYSTAL STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION FROM DUF155 FAMILY (YP_292156.1) FROM PROCHLOROCOCCUS SP. NATL2A AT 1.80 A RESOLUTION  |   YP_292156.1, HYPOTHETICAL PROTEIN, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, STRUCTURAL GENOMICS-UNKNOWN FUNCTION COMPLEX 
4mjg:A   (SER103) to   (ALA162)  CRYSTAL STRUCTURE OF A DUF4853 FAMILY PROTEIN (ACTODO_00621) FROM ACTINOMYCES ODONTOLYTICUS ATCC 17982 AT 2.65 A RESOLUTION  |   PF16145 FAMILY, DUF4853, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, UNKNOWN FUNCTION, STRUCTURAL GENOMICS UNKNOWN FUNCTION 
4mjg:B   (SER103) to   (ALA162)  CRYSTAL STRUCTURE OF A DUF4853 FAMILY PROTEIN (ACTODO_00621) FROM ACTINOMYCES ODONTOLYTICUS ATCC 17982 AT 2.65 A RESOLUTION  |   PF16145 FAMILY, DUF4853, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, UNKNOWN FUNCTION, STRUCTURAL GENOMICS UNKNOWN FUNCTION 
2iug:A    (SER18) to    (PHE71)  CRYSTAL STRUCTURE OF THE PI3-KINASE P85 N-TERMINAL SH2 DOMAIN  |   TRANSFERASE, POLYMORPHISM, UBL CONJUGATION, PHOSPHORYLATION, P85, SH2, PI3K, SH2 DOMAIN, SH3 DOMAIN, PI3-KINASE, DISEASE MUTATION 
2iuh:A    (SER18) to    (PHE71)  CRYSTAL STRUCTURE OF THE PI3-KINASE P85 N-TERMINAL SH2 DOMAIN IN COMPLEX WITH C-KIT PHOSPHOTYROSYL PEPTIDE  |   TRANSFERASE, POLYMORPHISM, UBL CONJUGATION, PHOSPHORYLATION, P85, SH2, PI3K, SH2 DOMAIN, SH3 DOMAIN, PI3-KINASE, DISEASE MUTATION 
2iui:A    (SER18) to    (PHE71)  CRYSTAL STRUCTURE OF THE PI3-KINASE P85 N-TERMINAL SH2 DOMAIN IN COMPLEX WITH PDGFR PHOSPHOTYROSYL PEPTIDE  |   TRANSFERASE, POLYMORPHISM, UBL CONJUGATION, PHOSPHORYLATION, P85, SH2, PI3K, SH2 DOMAIN, SH3 DOMAIN, PI3-KINASE, DISEASE MUTATION 
2iui:B  (SER1018) to  (PHE1071)  CRYSTAL STRUCTURE OF THE PI3-KINASE P85 N-TERMINAL SH2 DOMAIN IN COMPLEX WITH PDGFR PHOSPHOTYROSYL PEPTIDE  |   TRANSFERASE, POLYMORPHISM, UBL CONJUGATION, PHOSPHORYLATION, P85, SH2, PI3K, SH2 DOMAIN, SH3 DOMAIN, PI3-KINASE, DISEASE MUTATION 
4mq9:C    (GLY43) to   (ASN130)  CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH GE23077  |   DNA-DIRECTED RNA POLYMERASE, TRANSCRIPTION, TRANSFERASE-ANTIBIOTIC COMPLEX 
1jtg:B    (THR96) to   (ASP163)  CRYSTAL STRUCTURE OF TEM-1 BETA-LACTAMASE / BETA-LACTAMASE INHIBITOR PROTEIN COMPLEX  |   PROTEIN-PROTEIN COMPLEX, TEM-1 BETA-LACTAMASE, BETA- LACTAMASE INHIBITOR PROTEIN, BLIP, HYDROLASE 
1jtg:D    (THR96) to   (ASP163)  CRYSTAL STRUCTURE OF TEM-1 BETA-LACTAMASE / BETA-LACTAMASE INHIBITOR PROTEIN COMPLEX  |   PROTEIN-PROTEIN COMPLEX, TEM-1 BETA-LACTAMASE, BETA- LACTAMASE INHIBITOR PROTEIN, BLIP, HYDROLASE 
3wz7:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (6)  |   ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3wz8:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (8)  |   ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1jyr:A    (PRO66) to   (LEU120)  XRAY STRUCTURE OF GRB2 SH2 DOMAIN COMPLEXED WITH A PHOSPHORYLATED PEPTIDE  |   RECEPTOR BINDING, REGULATORY, INHIBITOR, SIGNALING PROTEIN-INHIBITOR COMPLEX 
1w6f:B    (TYR69) to   (LEU141)  ARYLAMINE N-ACETYLTRANSFERASE FROM MYCOBACTERIUM SMEGMATIS WITH THE ANTI-TUBERCULAR DRUG ISONIAZID BOUND IN THE ACTIVE SITE.  |   NAT, TUBERCULOSIS, ACETYLTRANSFERASE, TRANSFERASE 
1w80:A   (GLY700) to   (ASN751)  CRYSTAL STRUCTURE OF THE ALPHA-ADAPTIN APPENDAGE DOMAIN, FROM THE AP2 ADAPTOR COMPLEX, BOUND TO 2 PEPTIDES FROM SYNAPTOJANIN170  |   ENDOCYTOSIS/EXOCYTOSIS, ENDOCYTOSIS, ALPHA-ADAPTIN APPENDAGE, ADAPTOR COMPLEX, AP2, SYNAPTOJANIN, EXOCYTOSIS, LIPID-BINDING 
4n94:A   (PRO196) to   (ALA258)  E. COLI SLIDING CLAMP IN COMPLEX WITH 3,4-DIFLUOROBENZAMIDE  |   SLIDING CLAMP, DNAN, TRANSFERASE 
4n95:A   (PRO196) to   (ALA258)  E. COLI SLIDING CLAMP IN COMPLEX WITH 5-CHLOROINDOLINE-2,3-DIONE  |   SLIDING CLAMP, DNAN, TRANSFERASE 
4n97:A   (ARG197) to   (ALA258)  E. COLI SLIDING CLAMP IN COMPLEX WITH 5-NITROINDOLE  |   SLIDING CLAMP, DNAN, TRANSFERASE 
2jks:A    (THR90) to   (GLU162)  CRYSTAL STRUCTURE OF THE THE BRADYZOITE SPECIFIC ANTIGEN BSR4 FROM TOXOPLASMA GONDII.  |   IMMUNE SYSTEM 
2k07:A    (ASP24) to    (VAL99)  SOLUTION NMR STRUCTURE OF HUMAN E2-LIKE UBIQUITIN-FOLD MODIFIER CONJUGATING ENZYME 1 (UFC1). NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR41  |   UFC1, UBIQUITIN CONJUGATING ENZYME, E2, UFM1, POLYMORPHISM, UBL CONJUGATION PATHWAY, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, UNKNOWN FUNCTION 
1kaf:D   (SER108) to   (TYR165)  DNA BINDING DOMAIN OF THE PHAGE T4 TRANSCRIPTION FACTOR MOTA (AA105-211)  |   ESCHERICHIA COLI; X-RAY CRYSTALLOGRAPHY; PROTEIN-DNA INTERACTIONS; STRUCTURAL GENOMICS; EUBACTERIAL PROMOTERS., TRANSCRIPTION 
2kc5:A    (PRO12) to    (PRO75)  SOLUTION STRUCTURE OF HYBE FROM ESCHERICHIA COLI  |   CHAPERONE 
2lnw:A   (GLU679) to   (ILE731)  IDENTIFICATION AND STRUCTURAL BASIS FOR A NOVEL INTERACTION BETWEEN VAV2 AND ARAP3  |   SIGNALING PROTEIN 
2lra:A    (GLY13) to    (PRO73)  NMR STRUCTURE OF SIGNAL SEQUENCE DELETED (SSD) RV0603 PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS WITHOUT N-TERMINAL HIS-TAG  |   SSD, IMMUNE SYSTEM 
4npr:A    (LEU40) to    (LYS92)  CRYSTAL STRUCTURE OF THE FAMILY 12 XYLOGLUCANASE FROM ASPERGILLUS NIVEUS  |   B-JELLY ROLL, XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4-GLUCANASE, HYDROLASE 
1kp0:B   (ARG296) to   (THR389)  THE CRYSTAL STRUCTURE ANALYSIS OF CREATINE AMIDINOHYDROLASE FROM ACTINOBACILLUS  |   ALPHA BETAL, 3-LAYER(ABA) SANDWICH, HYDROLASE 
2mc1:A   (GLU677) to   (ILE729)  SOLUTION STRUCTURE OF THE VAV1 SH2 DOMAIN COMPLEXED WITH A SYK-DERIVED SINGLY PHOSPHORYLATED PEPTIDE  |   SYK KINASE, TYROSINE KINASE, PHOSPHORYLATED PEPTIDE, PHOSPHOTYROSINE BINDING DOMAIN, B CELL SIGNALING PROTEIN, SIGNALING PROTEIN-PROTEIN BINDING COMPLEX 
4nwf:A    (THR12) to    (TYR66)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION  |   HYDROLASE 
4nwf:B    (THR12) to    (TYR66)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION  |   HYDROLASE 
4nwg:A    (THR12) to    (TYR66)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION  |   HYDROLASE 
4nwg:B    (THR12) to    (TYR66)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION  |   HYDROLASE 
3zxu:A   (ASP195) to   (ASN270)  CRYSTAL STRUCTURE OF THE CTF19-MCM21 KINETOCHORE HETERODIMER FROM YEAST  |   CELL CYCLE, COMA COMPLEX, PROTEIN COMPLEX, CELL DIVISION 
3zxu:B   (VAL178) to   (ASN243)  CRYSTAL STRUCTURE OF THE CTF19-MCM21 KINETOCHORE HETERODIMER FROM YEAST  |   CELL CYCLE, COMA COMPLEX, PROTEIN COMPLEX, CELL DIVISION 
3zxu:D   (VAL178) to   (ASN243)  CRYSTAL STRUCTURE OF THE CTF19-MCM21 KINETOCHORE HETERODIMER FROM YEAST  |   CELL CYCLE, COMA COMPLEX, PROTEIN COMPLEX, CELL DIVISION 
5cb9:A    (LEU16) to    (HIS65)  CRYSTAL STRUCTURE OF C-AS LYASE WITH MERCAPTOETHONAL  |   ARSENIC, LYASE 
5cbp:A   (PRO121) to   (ASN182)  CRYSTAL STRUCTURE OF CONJOINT PYROCOCCUS FURIOSUS L-ASPARAGINASE AT 37 DEGREE C  |   HYDROLASE 
1l3a:A   (SER154) to   (LYS224)  STRUCTURE OF THE PLANT TRANSCRIPTIONAL REGULATOR PBF-2  |   PBF-2, SINGLE STRAND DNA BINDING PROTEIN, PLANT, WHIRLY, TRANSCRIPTIONNAL ACTIVATOR, CYCLIC C4 SYMMETRY 
1l3a:B   (SER154) to   (THR223)  STRUCTURE OF THE PLANT TRANSCRIPTIONAL REGULATOR PBF-2  |   PBF-2, SINGLE STRAND DNA BINDING PROTEIN, PLANT, WHIRLY, TRANSCRIPTIONNAL ACTIVATOR, CYCLIC C4 SYMMETRY 
1l3a:C   (SER154) to   (THR223)  STRUCTURE OF THE PLANT TRANSCRIPTIONAL REGULATOR PBF-2  |   PBF-2, SINGLE STRAND DNA BINDING PROTEIN, PLANT, WHIRLY, TRANSCRIPTIONNAL ACTIVATOR, CYCLIC C4 SYMMETRY 
1l3a:D   (SER154) to   (THR223)  STRUCTURE OF THE PLANT TRANSCRIPTIONAL REGULATOR PBF-2  |   PBF-2, SINGLE STRAND DNA BINDING PROTEIN, PLANT, WHIRLY, TRANSCRIPTIONNAL ACTIVATOR, CYCLIC C4 SYMMETRY 
5cdw:E    (PRO14) to    (LEU68)  CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE  |   SH2 DOMAIN, PHOSPHOTYROSINE, LIGAND, W121G MUTATION, SIGNALING PROTEIN 
5cdw:C    (PRO14) to    (LEU68)  CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE  |   SH2 DOMAIN, PHOSPHOTYROSINE, LIGAND, W121G MUTATION, SIGNALING PROTEIN 
5cdw:H    (PRO14) to    (LEU68)  CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE  |   SH2 DOMAIN, PHOSPHOTYROSINE, LIGAND, W121G MUTATION, SIGNALING PROTEIN 
5cdw:L    (PRO14) to    (LEU68)  CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE  |   SH2 DOMAIN, PHOSPHOTYROSINE, LIGAND, W121G MUTATION, SIGNALING PROTEIN 
5cdw:P    (PRO14) to    (LEU68)  CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE  |   SH2 DOMAIN, PHOSPHOTYROSINE, LIGAND, W121G MUTATION, SIGNALING PROTEIN 
5cdw:V    (PRO14) to    (LEU68)  CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE  |   SH2 DOMAIN, PHOSPHOTYROSINE, LIGAND, W121G MUTATION, SIGNALING PROTEIN 
5cdw:Z    (PRO14) to    (LEU68)  CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE  |   SH2 DOMAIN, PHOSPHOTYROSINE, LIGAND, W121G MUTATION, SIGNALING PROTEIN 
5cdw:d    (ARG15) to    (LEU68)  CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE  |   SH2 DOMAIN, PHOSPHOTYROSINE, LIGAND, W121G MUTATION, SIGNALING PROTEIN 
4o9d:A   (PRO384) to   (THR441)  STRUCTURE OF DOS1 PROPELLER  |   PROPELLER, HETEROCHROMATIN FORMATION, RIK1, DOS2, TRANSCRIPTION, GENE REGULATION 
4o9x:A   (MET418) to   (SER480)  CRYSTAL STRUCTURE OF TCDB2-TCCC3  |   BETA SHEET, COCOON, UNFOLDING, TC TOXIN, TOXIN 
3k2m:B   (SER152) to   (VAL205)  CRYSTAL STRUCTURE OF MONOBODY HA4/ABL1 SH2 DOMAIN COMPLEX  |   ENGINEERED BINDING PROTEIN, ANTIBODY MIMIC, PROTEIN-PROTEIN COMPLEX, SH2 DOMAIN, ATP-BINDING, PHOSPHOPROTEIN, TYROSINE-PROTEIN KINASE, SIGNALING PROTEIN, SIGNALING PROTEIN-PROTEIN BINDING COMPLEX 
1lk9:A     (MET6) to    (GLY56)  THE THREE-DIMENSIONAL STRUCTURE OF ALLIINASE FROM GARLIC  |   EGF-LIKE DOMAIN, PLP TYPE 1, CHLORIDE BINDING, LYASE 
1lk9:B     (MET6) to    (GLY56)  THE THREE-DIMENSIONAL STRUCTURE OF ALLIINASE FROM GARLIC  |   EGF-LIKE DOMAIN, PLP TYPE 1, CHLORIDE BINDING, LYASE 
3k44:B    (ALA86) to   (PRO164)  CRYSTAL STRUCTURE OF DROSOPHILA MELANOGASTER PUR-ALPHA  |   PUR-ALPHA, PUR REPEAT, PUR DOMAIN, WHIRLY FOLD, DNA BINDING PROTEIN, RNA BINDING PROTEIN, NUCLEIC ACID BINDING PROTEIN 
3k44:D    (ALA86) to   (PRO164)  CRYSTAL STRUCTURE OF DROSOPHILA MELANOGASTER PUR-ALPHA  |   PUR-ALPHA, PUR REPEAT, PUR DOMAIN, WHIRLY FOLD, DNA BINDING PROTEIN, RNA BINDING PROTEIN, NUCLEIC ACID BINDING PROTEIN 
4ohe:A    (THR12) to    (TYR66)  LEOPARD SYNDROME-ASSOCIATED SHP2/G464A MUTANT  |   SH2 DOMAIN, PHOSPHATASE DOMAIN, HYDROLASE 
4ohe:A   (SER118) to   (VAL181)  LEOPARD SYNDROME-ASSOCIATED SHP2/G464A MUTANT  |   SH2 DOMAIN, PHOSPHATASE DOMAIN, HYDROLASE 
4ohd:A   (SER118) to   (VAL181)  LEOPARD SYNDROME-ASSOCIATED SHP2/A461T MUTANT  |   SH2 DOMAIN, PHOSPHATASE DOMAIN, HYDROLASE 
4ohi:A    (THR12) to    (TYR66)  LEOPARD SYNDROME-ASSOCIATED SHP2/Q510E MUTANT  |   SH2 DOMAIN, PHOSPHATASE DOMAIN, HYDROLASE 
4ohl:A    (THR12) to    (TYR66)  LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT  |   SH2 DOMAIN, PHOSPHATASE DOMAIN, HYDROLASE 
4ohl:A   (SER118) to   (VAL181)  LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT  |   SH2 DOMAIN, PHOSPHATASE DOMAIN, HYDROLASE 
4ohl:B   (SER118) to   (VAL181)  LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT  |   SH2 DOMAIN, PHOSPHATASE DOMAIN, HYDROLASE 
2z6p:A    (ARG25) to    (VAL99)  CRYSTAL STRUCTURE OF THE UFC1, UFM1 CONJUGATING ENZYME 1  |   UFC1, UFM1, UBIQUITIN, UBL, POLYMORPHISM, UBL CONJUGATION PATHWAY, LIGASE 
2z8u:B    (LEU22) to    (GLY65)  METHANOCOCCUS JANNASCHII TBP  |   TRANSCRIPTION, DNA-BINDING PROTEIN, TRANSCRIPTION FACTOR, TRANSCRIPTION REGULATION 
1xv2:A    (THR24) to    (GLU64)  CRYSTAL STRUCTURE OF A PROTEIN OF UNKNOWN FUNCTION SIMILAR TO ALPHA-ACETOLACTATE DECARBOXYLASE FROM STAPHYLOCOCCUS AUREUS  |   ALPHA-ACETOLACTATE, STAPHYLOCOCCUS AUREUS, STRUCTURAL GENOMICS, MCSG, MIDWEST CENTER FOR STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, UNKNOWN FUNCTION 
1xv2:B    (THR24) to    (GLU64)  CRYSTAL STRUCTURE OF A PROTEIN OF UNKNOWN FUNCTION SIMILAR TO ALPHA-ACETOLACTATE DECARBOXYLASE FROM STAPHYLOCOCCUS AUREUS  |   ALPHA-ACETOLACTATE, STAPHYLOCOCCUS AUREUS, STRUCTURAL GENOMICS, MCSG, MIDWEST CENTER FOR STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, UNKNOWN FUNCTION 
1xv2:C    (THR24) to    (GLU64)  CRYSTAL STRUCTURE OF A PROTEIN OF UNKNOWN FUNCTION SIMILAR TO ALPHA-ACETOLACTATE DECARBOXYLASE FROM STAPHYLOCOCCUS AUREUS  |   ALPHA-ACETOLACTATE, STAPHYLOCOCCUS AUREUS, STRUCTURAL GENOMICS, MCSG, MIDWEST CENTER FOR STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, UNKNOWN FUNCTION 
1xv2:D    (THR24) to    (GLU64)  CRYSTAL STRUCTURE OF A PROTEIN OF UNKNOWN FUNCTION SIMILAR TO ALPHA-ACETOLACTATE DECARBOXYLASE FROM STAPHYLOCOCCUS AUREUS  |   ALPHA-ACETOLACTATE, STAPHYLOCOCCUS AUREUS, STRUCTURAL GENOMICS, MCSG, MIDWEST CENTER FOR STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, UNKNOWN FUNCTION 
1xxm:C  (THR1096) to  (ASP1163)  THE MODULAR ARCHITECTURE OF PROTEIN-PROTEIN BINDING SITE  |   PROTEIN-PROTEIN COMPLEX; TEM-1 BETA-LACTAMASE; BETA-2 LACTAMASE INHIBITOR PROTEIN; BLIP, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, STRUCTURAL GENOMICS, HYDROLASE/HYDROLASE INHIBITOR COMPLEX 
2zsg:B   (THR266) to   (THR350)  CRYSTAL STRUCTURE OF X-PRO AMINOPEPTIDASE FROM THERMOTOGA MARITIMA MSB8  |   AMINOPEPTIDASE, HYDROLASE 
4ovu:B   (GLU341) to   (PHE392)  CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH NISH2 OF P85ALPHA  |   P110, P85, PI3KCA, PI3K, PIK3R1, PHOSPHATIDILYNOSITOL 3,4,5 TRIPHOSPHATE, PIP2, PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE, LIPID KINASE, PHOSPHOINOSITIDE, 3-KINASE, SIGNALING, PHOSPHATIDYLINOSITOL 3-KINASE 
5d0j:A   (SER437) to   (MET495)  GRB7 SH2 WITH INHIBITOR PEPTIDE  |   INHIBITOR, SH2, SIGNALING PROTEIN 
5d0j:C   (SER437) to   (MET495)  GRB7 SH2 WITH INHIBITOR PEPTIDE  |   INHIBITOR, SH2, SIGNALING PROTEIN 
2zw6:B   (ASP193) to   (ALA254)  CRYSTAL STRUCTURE OF BLEOMYCIN N-ACETYLTRANSFERASE FROM BLEOMYCIN-PRODUCING STREPTOMYCES VERTICILLUS ATCC15003  |   DIMER, TWO DOMAINS, TRANSFERASE 
5d16:A   (ALA390) to   (GLY467)  STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE DOUBLE MUTANT - A453V/D523N  |   TRANSPOSITION, TN7, DNA BINDING PROTEIN, CONFORMATIONAL TOGGLE 
5d2u:A    (PRO68) to   (GLN132)  CRYSTAL STRUCTURE OF TPPHA VARIANT - H39A  |   PP2C TYPE PHOSPHATASE, METAL BINDING PROTEIN 
5d7z:A    (LEU35) to    (GLY91)  CRYSTAL STRUCTURE OF GLYOXALASE I FROM ZEA MAYS  |   LYASE 
5d7z:A   (LEU165) to   (GLY221)  CRYSTAL STRUCTURE OF GLYOXALASE I FROM ZEA MAYS  |   LYASE 
4pef:A   (SER211) to   (ASP260)  DBR1 IN COMPLEX WITH SULFATE  |   NUCLEASE, PHOSPHODIESTERASE, METALLOHYDROLASE, METALLOPHOSPHOESTERASE, LARIAT RNA, HYDROLASE, METALLOENZYME 
4pef:D   (SER211) to   (PRO262)  DBR1 IN COMPLEX WITH SULFATE  |   NUCLEASE, PHOSPHODIESTERASE, METALLOHYDROLASE, METALLOPHOSPHOESTERASE, LARIAT RNA, HYDROLASE, METALLOENZYME 
4pef:E   (SER211) to   (ASP260)  DBR1 IN COMPLEX WITH SULFATE  |   NUCLEASE, PHOSPHODIESTERASE, METALLOHYDROLASE, METALLOPHOSPHOESTERASE, LARIAT RNA, HYDROLASE, METALLOENZYME 
5dc0:B   (SER152) to   (VAL205)  CRYSTAL STRUCTURE OF MONOBODY GG3/ABL1 SH2 DOMAIN COMPLEX  |   ENGINEERED BINDING PROTEIN, ANTIBODY MIMIC, PROTEIN-PROTEIN COMPLEX, SH2 DOMAIN, TYROSINE-PROTEIN KINASE, PROTEIN BINDING 
5dc4:A   (SER152) to   (VAL205)  CRYSTAL STRUCTURE OF MONOBODY AS25/ABL1 SH2 DOMAIN COMPLEX, CRYSTAL A  |   ENGINEERED BINDING PROTEIN, ANTIBODY MIMIC, PROTEIN-PROTEIN COMPLEX, SH2 DOMAIN, TYROSINE-PROTEIN KINASE, PROTEIN BINDING 
3kxy:A     (LEU3) to    (ASP57)  CRYSTAL STRUCTURE OF THE EXSC-EXSE COMPLEX  |   TYPE-THREE SECRETION SYSTEM, TTSS, T3SS, CHAPERONE-EFFECTOR COMPLEX, CHAPERONE, EFFECTOR, CHAPERONE-TRANSCRIPTION INHIBITOR COMPLEX 
3kxy:C     (ASP2) to    (ASP57)  CRYSTAL STRUCTURE OF THE EXSC-EXSE COMPLEX  |   TYPE-THREE SECRETION SYSTEM, TTSS, T3SS, CHAPERONE-EFFECTOR COMPLEX, CHAPERONE, EFFECTOR, CHAPERONE-TRANSCRIPTION INHIBITOR COMPLEX 
3kxy:E     (SER5) to    (ASP57)  CRYSTAL STRUCTURE OF THE EXSC-EXSE COMPLEX  |   TYPE-THREE SECRETION SYSTEM, TTSS, T3SS, CHAPERONE-EFFECTOR COMPLEX, CHAPERONE, EFFECTOR, CHAPERONE-TRANSCRIPTION INHIBITOR COMPLEX 
3kxy:F     (LEU3) to    (ASP57)  CRYSTAL STRUCTURE OF THE EXSC-EXSE COMPLEX  |   TYPE-THREE SECRETION SYSTEM, TTSS, T3SS, CHAPERONE-EFFECTOR COMPLEX, CHAPERONE, EFFECTOR, CHAPERONE-TRANSCRIPTION INHIBITOR COMPLEX 
3kxy:G     (LEU3) to    (ASP57)  CRYSTAL STRUCTURE OF THE EXSC-EXSE COMPLEX  |   TYPE-THREE SECRETION SYSTEM, TTSS, T3SS, CHAPERONE-EFFECTOR COMPLEX, CHAPERONE, EFFECTOR, CHAPERONE-TRANSCRIPTION INHIBITOR COMPLEX 
3kxy:H     (ASP2) to    (ASP57)  CRYSTAL STRUCTURE OF THE EXSC-EXSE COMPLEX  |   TYPE-THREE SECRETION SYSTEM, TTSS, T3SS, CHAPERONE-EFFECTOR COMPLEX, CHAPERONE, EFFECTOR, CHAPERONE-TRANSCRIPTION INHIBITOR COMPLEX 
3kzs:D   (LYS360) to   (SER416)  CRYSTAL STRUCTURE OF GLYCOSYL HYDROLASE FAMILY 5 (NP_809925.1) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 2.10 A RESOLUTION  |   GLYCOSYL HYDROLASE FAMILY 5, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, HYDROLASE 
3l2z:B    (PRO94) to   (ASN158)  CRYSTAL STRUCTURE OF HYDRATED BIOTIN PROTEIN LIGASE FROM M. TUBERCULOSIS  |   BIRA, HYDRATED STRUCTURE, DISORDERED LIGAND BINDING LOOPS, LIGASE 
1yw4:A     (SER6) to    (CYS53)  CRYSTAL STRUCTURE OF THE SUCCINYLGLUTAMATE DESUCCINYLASE FROM CHROMOBACTERIUM VIOLACEUM, NORTHEAST STRUCTURAL GENOMICS TARGET CVR22.  |   ALPHA-BETA PROTEIN, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, HYDROLASE 
4pnv:B    (PRO71) to   (THR129)  E. COLI SLIDING CLAMP APO-CRYSTAL IN P21 SPACE GROUP WITH LARGER CELL DIMENSIONS  |   POLIII BETA, SLIDING CLAMP, DNAN, TRANSFERASE 
1z3k:A    (ARG10) to    (GLY63)  STRUCTURAL INSIGHT INTO THE BINDING DIVERSITY BETWEEN THE TYR-PHOSPHORYLATED HUMAN EPHRINBS AND NCK2 SH2 DOMAIN  |   NCK2, SH2 DOMAIN, EPH RECEPTOR-EPHRIN MEDIATED SIGNALING, STRUCTURAL GENOMICS, UNKNOWN FUNCTION 
5dod:E   (GLU193) to   (PRO259)  HUMAN A20 OTU DOMAIN WITH I325N AND ALKYLATED C103 TO 2.5A RESOLUTION  |   UBIQUITIN PROTEASE, HYDROLASE 
5dq1:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 34  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dq4:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 66  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dq5:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 209  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dq6:A   (GLU193) to   (PRO259)  MUS MUSCULUS A20 OTU DOMAIN  |   A20 OTU, HYDROLASE 
5dr0:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 203  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dr1:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 278  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dr8:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 330  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4ape:A   (PRO224) to   (PRO269)  THE ACTIVE SITE OF ASPARTIC PROTEINASES  |   HYDROLASE (ACID PROTEINASE) 
5dt5:D   (GLN367) to   (TRP426)  CRYSTAL STRUCTURE OF THE GH1 BETA-GLUCOSIDASE FROM EXIGUOBACTERIUM ANTARCTICUM B7 IN SPACE GROUP P21  |   GH1 FAMILY, BETA-GLUCOSIDASE, COLD-ACTIVE, TETRAMER, HYDROLASE 
5dt7:B   (GLN367) to   (TRP426)  CRYSTAL STRUCTURE OF THE GH1 BETA-GLUCOSIDASE FROM EXIGUOBACTERIUM ANTARCTICUM B7 IN SPACE GROUP C2221  |   GH1 FAMILY, BETA-GLUCOSIDASE, COLD-ACTIVE, TETRAMER, HYDROLASE 
5dt7:C   (GLN367) to   (TRP426)  CRYSTAL STRUCTURE OF THE GH1 BETA-GLUCOSIDASE FROM EXIGUOBACTERIUM ANTARCTICUM B7 IN SPACE GROUP C2221  |   GH1 FAMILY, BETA-GLUCOSIDASE, COLD-ACTIVE, TETRAMER, HYDROLASE 
5dt7:D   (GLN367) to   (TRP426)  CRYSTAL STRUCTURE OF THE GH1 BETA-GLUCOSIDASE FROM EXIGUOBACTERIUM ANTARCTICUM B7 IN SPACE GROUP C2221  |   GH1 FAMILY, BETA-GLUCOSIDASE, COLD-ACTIVE, TETRAMER, HYDROLASE 
3ll7:A   (ASP211) to   (THR272)  CRYSTAL STRUCTURE OF PUTATIVE METHYLTRANSFERASE PG_1098 FROM PORPHYROMONAS GINGIVALIS W83  |   METHYTRANSFERASE, STRUCTURAL GENOMICS, MCSG, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, TRANSFERASE 
1zsw:A   (LEU167) to   (PRO215)  CRYSTAL STRUCTURE OF BACILLUS CEREUS METALLO PROTEIN FROM GLYOXALASE FAMILY  |   HYPOTHETICAL PROTEIN FROM GLYOXALASE FAMILY, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, UNKNOWN FUNCTION 
3lzy:A   (PRO228) to   (PRO274)  CRYSTAL STRUCTURE OF ENDOTHIAPESIN IN COMPLEX WITH XENON  |   PROTEIN-XE COMPLEX, HYDROLASE, B-SECRETASE, ENDOTHIAPEPSIN, ASPARTYL PROTEASE, PROTEASE, ZYMOGEN 
5eel:B   (SER437) to   (MET495)  GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR  |   SH2, INHIBITOR, BICYCLIC, SIGNALING PROTEIN-PEPTIDE COMPLEX 
5eel:C   (SER437) to   (MET495)  GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR  |   SH2, INHIBITOR, BICYCLIC, SIGNALING PROTEIN-PEPTIDE COMPLEX 
5eel:D   (SER437) to   (MET495)  GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR  |   SH2, INHIBITOR, BICYCLIC, SIGNALING PROTEIN-PEPTIDE COMPLEX 
5eel:E   (SER437) to   (MET495)  GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR  |   SH2, INHIBITOR, BICYCLIC, SIGNALING PROTEIN-PEPTIDE COMPLEX 
2a8e:A    (PHE41) to   (TRP100)  THREE-DIMENSIONAL STRUCTURE OF BACILLUS SUBTILIS Q45498 PUTATIVE PROTEIN AT RESOLUTION 2.5A. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR204.  |   X-RAY, NESG, Q45498, YKTB, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, UNKNOWN FUNCTION 
5ehp:A    (THR12) to    (TYR66)  NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP836  |   PHOSPHATASE PTP INHIBITOR PTPN11 ALLOSTERIC, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5ehp:B    (THR12) to    (TYR66)  NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP836  |   PHOSPHATASE PTP INHIBITOR PTPN11 ALLOSTERIC, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2abl:A   (SER152) to   (VAL205)  SH3-SH2 DOMAIN FRAGMENT OF HUMAN BCR-ABL TYROSINE KINASE  |   TRANSFERASE, TYROSINE KINASE, SH3, SH2, ONCOPROTEIN 
4bgf:B    (GLU72) to   (LEU141)  THE 3D-STRUCTURE OF ARYLAMINE-N-ACETYLTRANSFERASE FROM M. TUBERCULOSIS  |   TRANSFERASE, DRUG DESIGN, CROSS-SEEDING, MICRO-SEEDING, MICROSEED MATRIX SCREEN, 
3mqz:A    (SER27) to   (VAL107)  CRYSTAL STRUCTURE OF CONSERVED PROTEIN DUF1054 FROM PINK SUBAERIAL BIOFILM MICROBIAL LEPTOSPIRILLUM SP. GROUP II UBA.  |   ALPHA-BETA FOLD, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, UNKNOWN FUNCTION 
3mxy:A    (PRO66) to   (LEU120)  STRUCTURES OF GRB2-SH2 DOMAIN AND AICD PEPTIDE COMPLEXES REVEAL A CONFORMATIONAL SWITCH AND THEIR FUNCTIONAL IMPLICATIONS.  |   PROTEIN-PEPTIDE COMPLEX, AICD, GRB2-SH2, PROTEIN BINDING, ALZHEIMER'S DISEASE, APP 
4bt3:A    (THR44) to    (GLU84)  ACETOLACTATE DECARBOXYLASE WITH A BOUND (2R,3R)-2,3- DIHYDROXY-2-METHYLBUTANOIC ACID  |   LYASE, ACETOIN BIOSYNTHESIS, STEREOSELECTIVE DECARBOXYLATION, BIFUNCTIONAL ENZYME 
4bt5:A    (THR44) to    (GLU84)  ACETOLACTATE DECARBOXYLASE WITH A BOUND (2S,3R)-2,3- DIHYDROXY-2-METHYLBUTANOIC ACID  |   LYASE, ACETOIN BIOSYNTHESIS, STEREOSELECTIVE DECARBOXYLATION, BIFUNCTIONAL ENZYME 
4bt6:A    (THR44) to    (GLU84)  ACETOLACTATE DECARBOXYLASE WITH A BOUND GLYCEROL  |   LYASE, ACETOIN BIOSYNTHESIS, STEREOSELECTIVE DECARBOXYLATION, BIFUNCTIONAL ENZYME 
3n1j:A   (SER119) to   (PRO186)  CRYSTAL STRUCTURE OF A STWHY2-DT32 COMPLEX  |   SINGLE-STRANDED DNA BINDING PROTEIN, PLANT, WHIRLY, PROTEIN-DNA COMPLEX, DNA BINDING PROTEIN-DNA COMPLEX 
3n4r:B    (SER71) to   (PRO136)  STRUCTURE OF CSM1 C-TERMINAL DOMAIN, R3 FORM  |   MEIOSIS, RDNA, REPLICATION 
3n4x:A    (SER17) to   (PRO136)  STRUCTURE OF CSM1 FULL-LENGTH  |   MEIOSIS, RDNA, REPLICATION 
3n4x:D     (LEU4) to   (PRO136)  STRUCTURE OF CSM1 FULL-LENGTH  |   MEIOSIS, RDNA, REPLICATION 
3n7y:C    (PRO66) to   (LEU120)  CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 20-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNV  |   LIGAND PREORGANIZATION, MACROCYCLES, MACROCYCLIC LIGANDS, GOLGI APPARATUS, HOST-VIRUS INTERACTION, PHOSPHOPROTEIN, PROTEIN BINDING- PEPTIDE COMPLEX 
5fgp:A    (SER98) to   (PRO164)  CRYSTAL STRUCTURE OF D. MELANOGASTER PUR-ALPHA REPEAT I-II IN COMPLEX WITH DNA.  |   DNA-PROTEIN INTERACTION, RNA-PROTEIN INTERACTION, DNA UNWINDING, FXTAS, ALS, FTLD, 5Q31.3 MICRODELETION SYNDROME, NEURODEGENERATION, DNA BINDING PROTEIN 
3c7v:D    (THR96) to   (ASP163)  STRUCTURAL INSIGHT INTO THE KINETICS AND DELTA-CP OF INTERACTIONS BETWEEN TEM-1 BETA-LACTAMASE AND BLIP  |   ENZYME-INHIBITOR COMPLEX, ANTIBIOTIC RESISTANCE, HYDROLASE, PLASMID, SECRETED, HYDROLASE/HYDROLASE INHIBITOR COMPLEX 
3n8m:A    (PRO66) to   (LEU120)  CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH AN ACYCLIC LIGAND HAVING THE SEQUENCE PYVNVP  |   GRB2 SH2 DOMAIN, LIGAND PREORGANIZATION, MACROCYCLES, MACROCYCLIC LIGANDS, PROTEIN BINDING-PEPTIDE COMPLEX 
4ra6:A   (GLU115) to   (ASN182)  CRYSTAL STRUCTURE OF LINKER LESS PYROCOCCUS FURIOSUS L-ASPARAGINASE  |   HYDROLASE 
4ra6:P   (PRO121) to   (ASN182)  CRYSTAL STRUCTURE OF LINKER LESS PYROCOCCUS FURIOSUS L-ASPARAGINASE  |   HYDROLASE 
3cea:A   (ASN186) to   (GLY257)  CRYSTAL STRUCTURE OF MYO-INOSITOL 2-DEHYDROGENASE (NP_786804.1) FROM LACTOBACILLUS PLANTARUM AT 2.40 A RESOLUTION  |   NP_786804.1, MYO-INOSITOL 2-DEHYDROGENASE, OXIDOREDUCTASE FAMILY, NAD-BINDING ROSSMANN FOLD, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE 
4rgz:A   (GLU279) to   (THR361)  CRYSTAL STRUCTURE OF RECOMBINANT PROLIDASE FROM THERMOCOCCUS SIBIRICUS AT P21221 SPACEGROUP  |   AMINOPEPTIDASE, DIPEPTIDASES, HYDROLASE 
4rgz:N   (GLU279) to   (THR361)  CRYSTAL STRUCTURE OF RECOMBINANT PROLIDASE FROM THERMOCOCCUS SIBIRICUS AT P21221 SPACEGROUP  |   AMINOPEPTIDASE, DIPEPTIDASES, HYDROLASE 
4rgz:1   (GLU279) to   (THR361)  CRYSTAL STRUCTURE OF RECOMBINANT PROLIDASE FROM THERMOCOCCUS SIBIRICUS AT P21221 SPACEGROUP  |   AMINOPEPTIDASE, DIPEPTIDASES, HYDROLASE 
4rgz:e   (GLU279) to   (THR361)  CRYSTAL STRUCTURE OF RECOMBINANT PROLIDASE FROM THERMOCOCCUS SIBIRICUS AT P21221 SPACEGROUP  |   AMINOPEPTIDASE, DIPEPTIDASES, HYDROLASE 
3ck6:A    (ARG51) to   (ARG108)  CRYSTAL STRUCTURE OF ZNTB CYTOPLASMIC DOMAIN FROM VIBRIO PARAHAEMOLYTICUS RIMD 2210633  |   APC91421.1, ZNTB, CYTOPLASMIC DOMAIN, VIBRIO PARAHAEMOLYTICUS RIMD 2210633, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, STRUCTURAL PROTEIN 
3ck6:B    (ARG51) to   (ARG108)  CRYSTAL STRUCTURE OF ZNTB CYTOPLASMIC DOMAIN FROM VIBRIO PARAHAEMOLYTICUS RIMD 2210633  |   APC91421.1, ZNTB, CYTOPLASMIC DOMAIN, VIBRIO PARAHAEMOLYTICUS RIMD 2210633, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, STRUCTURAL PROTEIN 
3ck6:C    (ARG51) to   (ARG108)  CRYSTAL STRUCTURE OF ZNTB CYTOPLASMIC DOMAIN FROM VIBRIO PARAHAEMOLYTICUS RIMD 2210633  |   APC91421.1, ZNTB, CYTOPLASMIC DOMAIN, VIBRIO PARAHAEMOLYTICUS RIMD 2210633, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, STRUCTURAL PROTEIN 
3ck6:D    (ARG51) to   (ARG108)  CRYSTAL STRUCTURE OF ZNTB CYTOPLASMIC DOMAIN FROM VIBRIO PARAHAEMOLYTICUS RIMD 2210633  |   APC91421.1, ZNTB, CYTOPLASMIC DOMAIN, VIBRIO PARAHAEMOLYTICUS RIMD 2210633, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, STRUCTURAL PROTEIN 
4roj:A   (ARG680) to   (ILE731)  CRYSTAL STRUCTURE OF THE VAV2 SH2 DOMAIN IN COMPLEX WITH TXNIP PHOSPHORYLATED PEPTIDE  |   STRUCTURAL GENOMICS, SH2 DOMAIN, STRUCTURAL GENOMICS CONSORTIUM, SGC, LIGASE 
4roj:B   (LEU687) to   (ILE731)  CRYSTAL STRUCTURE OF THE VAV2 SH2 DOMAIN IN COMPLEX WITH TXNIP PHOSPHORYLATED PEPTIDE  |   STRUCTURAL GENOMICS, SH2 DOMAIN, STRUCTURAL GENOMICS CONSORTIUM, SGC, LIGASE 
4roj:C   (ARG680) to   (ILE731)  CRYSTAL STRUCTURE OF THE VAV2 SH2 DOMAIN IN COMPLEX WITH TXNIP PHOSPHORYLATED PEPTIDE  |   STRUCTURAL GENOMICS, SH2 DOMAIN, STRUCTURAL GENOMICS CONSORTIUM, SGC, LIGASE 
3csv:A     (SER3) to    (GLN59)  CRYSTAL STRUCTURE OF A PUTATIVE AMINOGLYCOSIDE PHOSPHOTRANSFERASE (YP_614837.1) FROM SILICIBACTER SP. TM1040 AT 2.15 A RESOLUTION  |   YP_614837.1, PUTATIVE AMINOGLYCOSIDE PHOSPHOTRANSFERASE, PHOSPHOTRANSFERASE ENZYME FAMILY, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, TRANSFERASE 
4rt5:A    (VAL26) to    (THR73)  THE CRYSTAL STRUCTURE OF A GLYOXALASE/BLEOMYCIN RESISTANCE PROTEIN/DIOXYGENASE PROTEIN FROM PLANCTOMYCES LIMNOPHILUS DSM 3776  |   OXIDOREDUCTASE, STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, A/B FOLD, CYTOSOLIC 
3d4a:C    (SER15) to    (ARG96)  CRYSTAL STRUCTURE OF RIBONUCLEASE SA2 WITH 3'-GMP OBTAINED BY LIGAND DIFFUSION  |   RIBONUCLEASE, MONONUCLEOTIDE, PROTEIN-MONONUCLEOTIDE COMPLEX, HYDROLASE 
3d5g:C    (SER15) to    (ARG96)  STRUCTURE OF RIBONUCLEASE SA2 COMPLEXES WITH MONONUCLEOTIDES: NEW ASPECTS OF CATALYTIC REACTION AND SUBSTRATE RECOGNITION  |   RIBONUCLEASE, HYDROLASE 
3d5i:B    (SER15) to    (ARG96)  CRYSTAL STRUCTURE OF RIBONUCLEASE SA2 WITH EXO-2',3'- CYCLOPHOSPHOROTIOATE  |   RIBONUCLEASE, MONONUCLEOTIDE, PROTEIN-MONONUCLEOTIDE COMPLEX, EXO-2', 3'-CYCLOPHOSPHOROTIOATE, HYDROLASE 
3d5i:C    (SER15) to    (ARG96)  CRYSTAL STRUCTURE OF RIBONUCLEASE SA2 WITH EXO-2',3'- CYCLOPHOSPHOROTIOATE  |   RIBONUCLEASE, MONONUCLEOTIDE, PROTEIN-MONONUCLEOTIDE COMPLEX, EXO-2', 3'-CYCLOPHOSPHOROTIOATE, HYDROLASE 
5gkp:A    (SER64) to   (LYS118)  CRYSTAL STRUCTURE OF THE ENDOG WORM HOMOLOGUE CPS-6 H148A/F122A IN COMPLEX WITH DNA  |   ENDOG, MITOCHONDRIA, ENDONUCLEASE, NON-SPECIFIC NUCLEASE, PROTEIN-DNA INTERACTIONS, HYDROLASE-DNA COMPLEX 
4u17:B    (ARG20) to    (THR81)  SWAPPED DIMER OF THE HUMAN FYN-SH2 DOMAIN  |   HUMAN FYN-SH2 DOMAIN, DOMAIN SWAPPING, TRANSFERASE 
4u2x:A   (LEU147) to   (HIS223)  EBOLA VIRUS VP24 IN COMPLEX WITH KARYOPHERIN ALPHA 5 C-TERMINUS  |   EVP24, IMPORTIN ALPHA6, IMMUNE ANTAGONIST 
4u2x:B   (LEU147) to   (HIS223)  EBOLA VIRUS VP24 IN COMPLEX WITH KARYOPHERIN ALPHA 5 C-TERMINUS  |   EVP24, IMPORTIN ALPHA6, IMMUNE ANTAGONIST 
4u2x:C   (LEU147) to   (HIS223)  EBOLA VIRUS VP24 IN COMPLEX WITH KARYOPHERIN ALPHA 5 C-TERMINUS  |   EVP24, IMPORTIN ALPHA6, IMMUNE ANTAGONIST 
4dfc:C   (ARG138) to   (ARG193)  CORE UVRA/TRCF COMPLEX  |   ALPHA/BETA DOMAINS, DNA REPAIR, ATP BINDING, DNA BINDING, NUCLEOTIDE EXCISION REPAIR, HYDROLASE-DNA BINDING PROTEIN COMPLEX 
4dlo:A   (GLY670) to   (PRO742)  CRYSTAL STRUCTURE OF THE GAIN AND HORMR DOMAINS OF BRAIN ANGIOGENESIS INHIBITOR 3 (BAI3)  |   GAIN DOMAIN, INCLUDES GPS MOTIF, AUTOPROTEOLYTIC FOLD, EXTRACELLULAR, SIGNALING PROTEIN 
3e2k:C    (THR96) to   (ASP163)  CRYSTAL STRUCTURE OF THE KPC-2 BETA-LACTAMASE/BETA-LACTAMASE INHIBITOR PROTEIN (BLIP)  |   BETA-LACTAMASE, BETA-LACTAMASE INHIBITOR PROTEIN, PROTEIN- PROTEIN COMPLEX, BLIP, KPC-2, ANTIBIOTIC RESISTANCE, HYDROLASE, PLASMID, SECRETED, HYDROLASE/HYDROLASE INHIBITOR COMPLEX 
3e2l:C    (THR96) to   (ASP163)  CRYSTAL STRUCTURE OF THE KPC-2 BETA-LACTAMASE/BETA-LACTAMASE INHIBITOR PROTEIN (BLIP)  |   BETA-LACTAMASE, BETA-LACTAMASE INHIBITOR PROTEIN, PROTEIN- PROTEIN COMPLEX, BLIP, KPC-2, ANTIBIOTIC RESISTANCE, HYDROLASE, PLASMID, SECRETED, HYDROLASE/HYDROLASE INHIBITOR COMPLEX 
3e2l:D    (THR96) to   (ASP163)  CRYSTAL STRUCTURE OF THE KPC-2 BETA-LACTAMASE/BETA-LACTAMASE INHIBITOR PROTEIN (BLIP)  |   BETA-LACTAMASE, BETA-LACTAMASE INHIBITOR PROTEIN, PROTEIN- PROTEIN COMPLEX, BLIP, KPC-2, ANTIBIOTIC RESISTANCE, HYDROLASE, PLASMID, SECRETED, HYDROLASE/HYDROLASE INHIBITOR COMPLEX 
3pbd:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pbz:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pcw:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pgi:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pld:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pm4:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pmy:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5i6v:B   (SER118) to   (VAL181)  STRUCTURE OF F285S, A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2  |   SHP2, CANCER-ASSOCIATED MUTATION, INHIBITORS, HYDROLASE 
5ibm:B    (THR12) to    (TYR66)  STRUCTURE OF S502P, A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2  |   TYROSINE PHOSPHATASE SHP2 S502P, TYROSINE-PROTEIN PHOSPHATASE NON- RECEPTOR TYPE 11, HYDROLASE 
5ibs:A    (THR12) to    (TYR66)  STRUCTURE OF E76Q, A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2  |   TYROSINE PHOSPHATASE SHP2, TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11, HYDROLASE 
3pqs:A    (ASN83) to   (PRO141)  THE CRYSTAL STRUCTURES OF PORCINE PATHOGEN APH87_TBPB  |   LIPOPROTEIN, TRANSFERRIN RECEPTOR, IRON ACQUISITION, VACCINE CANDIDATE, BETA BARREL, TRANSFERRIN BINDING, TRANSFERRIN, OUTERMEMBRANE, LIPID BINDING PROTEIN 
3pqz:A   (SER437) to   (MET495)  GRB7 SH2 WITH PEPTIDE  |   SH2, BINDS PHOSPHOTYROSINE, TYROSINE KINASES, CYTOPLASMIC, PROTEIN BINDING 
3pqz:B   (SER437) to   (MET495)  GRB7 SH2 WITH PEPTIDE  |   SH2, BINDS PHOSPHOTYROSINE, TYROSINE KINASES, CYTOPLASMIC, PROTEIN BINDING 
3pqz:C   (SER437) to   (MET495)  GRB7 SH2 WITH PEPTIDE  |   SH2, BINDS PHOSPHOTYROSINE, TYROSINE KINASES, CYTOPLASMIC, PROTEIN BINDING 
3pqz:D   (SER437) to   (MET495)  GRB7 SH2 WITH PEPTIDE  |   SH2, BINDS PHOSPHOTYROSINE, TYROSINE KINASES, CYTOPLASMIC, PROTEIN BINDING 
3prs:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH RITONAVIR  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3psk:B  (GLY1264) to  (ASP1325)  CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451)  |   TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION 
3psk:D  (THR1360) to  (VAL1420)  CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451)  |   TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION 
3psy:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pww:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH SAQUINAVIR  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ejy:A    (ASN21) to    (ASP63)  STRUCTURE OF MBOGG1 IN COMPLEX WITH HIGH AFFINITY DNA LIGAND  |   8-OXOGUANINE DNA GLYCOSYLASE, HYDROLASE-DNA COMPLEX 
4ejy:B    (ASN21) to    (ASP63)  STRUCTURE OF MBOGG1 IN COMPLEX WITH HIGH AFFINITY DNA LIGAND  |   8-OXOGUANINE DNA GLYCOSYLASE, HYDROLASE-DNA COMPLEX 
3q4k:A   (PRO196) to   (ALA258)  STRUCTURE OF A SMALL PEPTIDE LIGAND BOUND TO E.COLI DNA SLIDING CLAMP  |   DNA POLYMERASE, SLIDING CLAMP, PROCESSIVITY FACTORS, LIGAND BINDING, DNA REPLICATION, DNA-DIRECTED DNA POLYMERASE, NUCLEOTIDYLTRANSFERASE, TRANSFERASE, TRANSFERASE-PEPTIDE COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3q4j:A    (PRO71) to   (THR129)  STRUCTURE OF A SMALL PEPTIDE LIGAND BOUND TO E.COLI DNA SLIDING CLAMP  |   DNA POLYMERASE, SLIDING CLAMP, PROCESSIVITY FACTORS, LIGAND BINDING, DNA REPLICATION, DNA-DIRECTED DNA POLYMERASE, NUCLEOTIDYLTRANSFERASE, TRANSFERASE, TRANSFERASE-PEPTIDE COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4er1:E   (PRO224) to   (PRO269)  THE ACTIVE SITE OF ASPARTIC PROTEINASES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5iw5:A    (VAL76) to   (GLN145)  CRYSTAL STRUCTURE OF E. COLI NUDC IN COMPLEX WITH NMN  |   NMN, RNA, CAPPING, NUDIX, HYDROLASE 
4f59:A   (THR157) to   (ILE217)  TRIPLE MUTANT SRC SH2 DOMAIN  |   SH2 DOMAIN, CELL SIGNALLING, PHOSPHOTYROSINE BINDING, PROTEIN BINDING 
4fbp:A    (LYS72) to   (ARG140)  CONFORMATIONAL TRANSITION OF FRUCTOSE-1,6-BISPHOSPHATASE: STRUCTURE COMPARISON BETWEEN THE AMP COMPLEX (T FORM) AND THE FRUCTOSE 6-PHOSPHATE COMPLEX (R FORM)  |   HYDROLASE (PHOSPHORIC MONOESTER) 
4fbp:B    (ASP74) to   (ARG140)  CONFORMATIONAL TRANSITION OF FRUCTOSE-1,6-BISPHOSPHATASE: STRUCTURE COMPARISON BETWEEN THE AMP COMPLEX (T FORM) AND THE FRUCTOSE 6-PHOSPHATE COMPLEX (R FORM)  |   HYDROLASE (PHOSPHORIC MONOESTER) 
4fdi:A   (HIS150) to   (LEU205)  THE MOLECULAR BASIS OF MUCOPOLYSACCHARIDOSIS IV A  |   GLYCOPROTEIN, ENZYME REPLACEMENT THERAPY, SULFATASE, FORMYLGLYCINE, N-LINKED GLYCOSYLATION, LYSOSOMAL ENZYME, HYDROLASE 
4fdi:B   (HIS150) to   (LEU205)  THE MOLECULAR BASIS OF MUCOPOLYSACCHARIDOSIS IV A  |   GLYCOPROTEIN, ENZYME REPLACEMENT THERAPY, SULFATASE, FORMYLGLYCINE, N-LINKED GLYCOSYLATION, LYSOSOMAL ENZYME, HYDROLASE 
4v29:B   (PRO104) to   (TRP168)  THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS  |   LIPID BINDING PROTEIN, CALCIUM BINDING PROTEIN, C2 DOMAIN 
3qwy:A    (SER20) to    (ALA85)  CED-2  |   CELL ENGULFMENT, SIGNALING PROTEIN 
3r07:A    (ILE99) to   (ALA163)  STRUCTURAL ANALYSIS OF AN ARCHAEAL LIPOYLATION SYSTEM. A BI-PARTITE LIPOATE PROTEIN LIGASE AND ITS E2 LIPOYL DOMAIN FROM THERMOPLASMA ACIDOPHILUM  |   ADENYLATE-FORMING ENZYME, LIGASE, BI-PARTITE, ATP-BINDING, TRANSFERASE 
3r9z:A   (SER119) to   (THR188)  CRYSTAL STRUCTURE OF STWHY2 K67A (FORM II)  |   STWHY2, SINGLE-STRANDED DNA BINDING PROTEIN, PLANT, POTATO, WHIRLY, MITOCHONDRIA, DNA BINDING PROTEIN 
3ra0:A   (SER119) to   (THR188)  CRYSTAL STRUCTURE OF A STWHY2 K67A-DT32 COMPLEX  |   STWHY2, SINGLE-STRANDED DNA BINDING PROTEIN, PLANT, POTATO, WHIRLY, PROTEIN-DNA COMPLEX, MITOCHONDRIA, DNA BINDING PROTEIN-DNA COMPLEX 
5k9h:A   (PRO189) to   (THR227)  CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE 29 FAMILY MEMBER FROM AN UNKNOWN RUMEN BACTERIUM  |   TIM BARREL, BETA SANDWICH, DUAL CARBOHYDRATE BINDING MODULES, HYDROLASE 
4gl9:E    (GLY53) to   (LEU104)  CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN  |   KINASE INHIBITOR RECEPTOR CYTOKINE SIGNALLING, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5oys:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 3  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyu:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 5  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz0:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 11  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz5:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 16  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz7:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 18  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oza:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 21  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozb:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 22  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozc:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 23  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozd:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 24  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oze:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 25  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozf:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 26  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozg:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 27  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozh:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 28  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozi:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 29  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozm:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 33  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozn:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 34  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozo:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 35  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozp:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 36  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozr:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 38  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozs:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 39  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozt:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 40  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozu:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 41  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozw:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 43  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozx:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 44  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozz:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 46  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p02:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 49  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p04:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 51  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p06:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 53  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p07:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 54  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p08:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 55  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p09:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 56  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0b:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 58  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0d:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 60  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0f:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 62  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0g:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 63  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0h:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 64  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0i:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 65  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0j:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 66  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0k:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 67  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0l:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 68  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0m:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 69  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0n:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 70  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0o:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 71  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0p:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 72  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0q:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 73  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0r:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 74  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0s:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 75  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0t:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 76  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0u:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 77  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0v:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 78  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0x:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 80  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0y:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 81  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0z:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 82  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p10:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 83  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p11:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 84  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p12:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 85  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p14:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 87  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p15:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 88  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p16:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 89  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p17:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 90  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p18:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 91  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p19:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 92  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1b:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 94  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1d:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 96  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1e:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 97  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1f:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 98  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1g:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 99  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1i:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 101  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1j:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 102  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1l:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 104  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1p:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 108  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1r:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 110  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1s:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 111  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1u:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 113  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1w:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 115  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1x:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 116  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1y:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 117  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p20:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 119  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p22:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 120  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p25:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 123  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p28:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 126  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p29:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 127  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2d:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 131  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2f:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 133  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2g:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 134  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2k:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 138  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2l:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 139  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2m:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 140  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2n:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 141  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2o:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 142  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2q:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 143  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2r:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 144  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2t:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 146  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2u:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 147  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2v:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 148  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2w:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 149  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p31:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 154  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p32:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 155  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p33:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 156  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p34:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 157  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p35:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 158  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p38:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 161  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3c:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 165  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3d:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 166  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3e:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 167  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3g:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 169  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3i:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 171  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3l:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 174  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3m:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 175  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3o:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 177  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3q:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 179  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3t:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 182  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3u:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 183  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3w:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 185  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3x:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 186  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3y:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 187  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3z:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 188  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p40:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 189  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p41:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 190  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p42:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 191  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p43:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 192  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p44:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 193  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p45:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 194  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p46:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 195  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p47:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 196  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p48:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 197  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p49:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 198  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4a:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 199  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4b:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 200  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4c:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 201  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4d:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 202  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4e:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 203  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4f:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 204  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4h:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 206  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4k:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 209  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4l:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 210  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4m:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 211  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4o:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 213  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4q:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 215  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4r:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 216  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4s:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 217  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4v:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 220  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4w:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 221  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4y:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 223  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4z:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 224  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p53:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 228  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p54:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 229  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p55:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 230  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p56:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 231  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p58:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 233  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p59:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 234  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5a:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 235  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5c:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 237  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5d:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 238  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5e:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 239  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5f:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 240  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5g:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 241  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5h:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 242  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5i:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 243  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5j:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 244  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5k:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 245  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5l:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 246  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5m:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 247  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5o:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 249  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5q:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 251  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5r:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 252  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5s:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 253  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5t:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 254  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5u:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 255  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5v:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 256  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5w:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 257  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5x:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 258  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5y:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 259  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5z:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 260  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p61:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 262  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p63:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 264  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p64:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 265  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p65:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 266  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p66:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 267  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p68:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 269  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6a:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 271  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6e:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 275  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6g:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 277  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6h:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 278  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6i:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 279  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6j:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 280  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6l:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 282  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6m:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 283  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6n:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 284  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6o:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 285  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6p:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 286  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6q:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 287  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6r:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 288  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6s:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 289  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6t:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 290  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6u:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 291  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6v:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 292  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6y:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 295  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6z:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 296  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p70:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 297  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p71:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 298  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p72:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 299  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p76:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 303  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p77:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 304  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p78:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 305  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7a:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 307  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7b:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 308  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7d:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 310  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7e:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 311  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7i:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 315  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7j:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 316  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7m:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 319  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7n:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 320  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7p:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 322  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7q:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 323  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7t:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 326  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7u:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 327  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7v:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 328  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7w:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 329  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7x:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 330  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7y:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 331  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7z:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 332  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p80:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 333  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p81:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 334  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p82:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 335  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p83:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 336  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p84:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 337  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p85:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 338  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p86:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 339  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p87:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 340  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p88:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 341  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p89:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 342  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8a:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 343  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8b:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 344  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8c:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 345  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8d:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 346  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8e:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 347  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8f:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 348  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8h:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 350  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8j:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 352  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8k:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 353  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8l:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 354  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8m:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 355  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8n:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 356  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8o:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 357  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8p:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 358  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8r:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 360  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8s:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 361  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8t:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 362  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8u:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 363  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8v:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 364  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
2ope:C    (ASP58) to   (LYS124)  CRYSTAL STRUCTURE OF THE NEISSERIA MENINGITIDIS MINOR TYPE IV PILIN, PILX, IN SPACE GROUP P43  |   NEISSERIA MENINGITIDIS, TYPE IV PILIN, PILX, MINOR PILIN, BACTERIAL PATHOGENESIS, ADHESION, AGGREGATION, FILAMENT, CELL ADHESION 
1nzl:A   (THR156) to   (ILE216)  CRYSTAL STRUCTURE OF SRC SH2 DOMAIN BOUND TO DOUBLY PHOSPHORYLATED PEPTIDE PQPYEPYIPI  |   SH2 DOMAIN, PHOSPHOTYROSINE, TRANSFERASE 
4wwq:B   (SER437) to   (PHE493)  APO STRUCTURE OF THE GRB7 SH2 DOMAIN  |   SRC HOMOLOGY DOMAIN, PHOSPHOTYROSINE BINDING POCKET, SIGNALING PROTEIN 
1o49:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85493.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4b:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU83876.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4d:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78262.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4e:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78299.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1o4q:A    (THR13) to    (ILE73)  CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79256.  |   SH2 DOMAIN FRAGMENT APPROACH, SIGNALING PROTEIN 
1chm:A   (ARG297) to   (THR390)  ENZYMATIC MECHANISM OF CREATINE AMIDINOHYDROLASE AS DEDUCED FROM CRYSTAL STRUCTURES  |   CREATINASE 
2q17:A   (THR162) to   (GLY295)  FORMYLGLYCINE GENERATING ENZYME FROM STREPTOMYCES COELICOLOR  |   FGE, FORMYLGLYCINE, SULFATASE, UNKNOWN FUNCTION 
2q17:B   (THR162) to   (GLY295)  FORMYLGLYCINE GENERATING ENZYME FROM STREPTOMYCES COELICOLOR  |   FGE, FORMYLGLYCINE, SULFATASE, UNKNOWN FUNCTION 
2q17:C   (THR162) to   (GLY295)  FORMYLGLYCINE GENERATING ENZYME FROM STREPTOMYCES COELICOLOR  |   FGE, FORMYLGLYCINE, SULFATASE, UNKNOWN FUNCTION 
2q17:D   (THR162) to   (GLY295)  FORMYLGLYCINE GENERATING ENZYME FROM STREPTOMYCES COELICOLOR  |   FGE, FORMYLGLYCINE, SULFATASE, UNKNOWN FUNCTION 
2q17:E   (THR162) to   (GLY295)  FORMYLGLYCINE GENERATING ENZYME FROM STREPTOMYCES COELICOLOR  |   FGE, FORMYLGLYCINE, SULFATASE, UNKNOWN FUNCTION 
1p13:A   (THR167) to   (ILE227)  CRYSTAL STRUCTURE OF THE SRC SH2 DOMAIN COMPLEXED WITH PEPTIDE (SDPYANFK)  |   TYROSINE-PROTEIN KINASE, PHOSPHORYLATION, SH3 DOMAIN, TRANSFERASE 
3t6i:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH AN AZEPIN DERIVATIVE  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y39:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 75  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3f:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 78  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3z:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 41  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y41:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 112  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y4g:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B53  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y4x:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 51  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y50:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 81  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yd4:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 227  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yd7:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 255  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
2er9:E   (PRO224) to   (PRO269)  X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES.  |   HYDROLASE-HYDROLASE INHIBITOR, ACID PROTEINASE 
4k3s:A   (PRO196) to   (ALA258)  E. COLI SLIDING CLAMP IN P1 CRYSTAL SPACE GROUP  |   E. COLI SLIDING CLAMP, TRANSFERASE 
4ze6:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B39  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4kop:B   (SER116) to   (PRO183)  CRYSTAL STRUCTURE OF WHY2 FROM ARABIDOPSIS THALIANA  |   PLANT, WHIRLY, DNA BINDING PROTEIN 
4kop:D   (SER116) to   (PRO183)  CRYSTAL STRUCTURE OF WHY2 FROM ARABIDOPSIS THALIANA  |   PLANT, WHIRLY, DNA BINDING PROTEIN 
2gb5:B    (VAL76) to   (GLN145)  CRYSTAL STRUCTURE OF NADH PYROPHOSPHATASE (EC 3.6.1.22) (1790429) FROM ESCHERICHIA COLI K12 AT 2.30 A RESOLUTION  |   1790429, NADH PYROPHOSPHATASE (EC 3.6.1.22), STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, HYDROLASE 
4zrh:D   (GLU193) to   (THR262)  HUMAN A20 OTU DOMAIN WITH I325N AND ALKYLATED C103  |   UBIQUITIN PROTEASE, HYDROLASE 
4zrh:E   (GLU193) to   (THR262)  HUMAN A20 OTU DOMAIN WITH I325N AND ALKYLATED C103  |   UBIQUITIN PROTEASE, HYDROLASE 
3iur:A   (ASP116) to   (ASP171)  APPEP_D266NX+H2H3 OPENED STATE  |   PROLYL ENDOPEPTIDASE, HYDROLASE 
2him:D   (GLY128) to   (ASN191)  CRYSTAL STRUCTURE AND ALLOSTERIC REGULATION OF THE CYTOPLASMIC ESCHERICHIA COLI L-ASPARAGINASE I  |   ASPARAGINASE, HYDROLASE 
3vs0:A   (SER155) to   (SER216)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3vs6:A   (SER155) to   (ILE215)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR TERT-BUTYL {4-[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[3,4- D]PYRIMIDIN-3-YL]-2-METHOXYPHENYL}CARBAMATE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3vs6:B   (SER155) to   (ILE215)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR TERT-BUTYL {4-[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[3,4- D]PYRIMIDIN-3-YL]-2-METHOXYPHENYL}CARBAMATE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5a52:A    (ILE90) to   (ILE160)  THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR1 IN COMPLEX WITH ONE CALCIUM ION  |   LIPID BINDING PROTEIN, CALCIUM BINDING PROTEIN, C2 DOMAIN 
3wil:A   (THR129) to   (MET208)  CRYSTAL STRUCTURE OF THE CK2ALPHA/COMPOUND3 COMPLEX  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
1vqz:A    (ASP97) to   (LEU150)  CRYSTAL STRUCTURE OF A PUTATIVE LIPOATE-PROTEIN LIGASE A (SP_1160) FROM STREPTOCOCCUS PNEUMONIAE TIGR4 AT 1.99 A RESOLUTION  |   CLASS II AARS AND BIOTIN SYNTHETASES FOLD, SUFE/NIFU FOLD, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI, LIGASE 
1jyq:A    (PRO66) to   (LEU120)  XRAY STRUCTURE OF GRB2 SH2 DOMAIN COMPLEXED WITH A HIGHLY AFFINE PHOSPHO PEPTIDE  |   RECEPTOR BINDING, REGULATORY, SIGNALING PROTEIN-SIGNALING PROTEIN INHIBITOR, SIGNALING PROTEIN-PEPTIDE INHIBITOR COMPLEX 
4nhe:A   (TYR181) to   (ASN233)  THE CRYSTAL STRUCTURE OF OXIDOREDUCTASE (GFO/IDH/MOCA FAMILY) FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH NADP  |   STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, OXIDOREDUCTASE 
5c4p:A    (LEU16) to    (HIS65)  CRYSTAL STRUCTURE OF ARSI C-AS LYASE SOLVED BY NI-SAD PHASING  |   C-AS LYASE, NI-SAD, ARSENIC, OXIDOREDUCTASE 
3jts:D    (ALA74) to   (ALA136)  GY9-MAMU-A*02-HB2M  |   ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
2nvn:A    (THR36) to   (PRO104)  CRYSTAL STRUCTURE OF A PROTEIN WITH A CUPIN-LIKE FOLD AND UNKNOWN FUNCTION (YP_400729.1) FROM SYNECHOCOCCUS SP. PCC 7942 (ELONGATUS) AT 2.50 A RESOLUTION  |   YP_400729.1, HYPOTHETICAL PROTEIN, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, STRUCTURAL GENOMICS-UNKNOWN FUNCTION COMPLEX 
1m5q:1    (MSE82) to   (GLY121)  CRYSTAL STRUCTURE OF A NOVEL SM-LIKE ARCHAEAL PROTEIN FROM PYROBACULUM AEROPHILUM  |   OB-LIKE FOLD, B-SHEET TOROID, 14-MER, CADMIUM-BINDING SITE, TRANSLATION 
5d17:A   (PHE389) to   (SER461)  STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION  |   TRANSPOSITION, TN7, DNA BINDING PROTEINS, CONFORMATIONAL TOGGLE, DNA BINDING PROTEIN 
5d17:D   (PHE389) to   (SER461)  STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION  |   TRANSPOSITION, TN7, DNA BINDING PROTEINS, CONFORMATIONAL TOGGLE, DNA BINDING PROTEIN 
5d17:I   (ALA390) to   (SER461)  STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION  |   TRANSPOSITION, TN7, DNA BINDING PROTEINS, CONFORMATIONAL TOGGLE, DNA BINDING PROTEIN 
3kpa:A    (ASP25) to    (LEU98)  UBIQUITIN FOLD MODIFIER CONJUGATING ENZYME FROM LEISHMANIA MAJOR (PROBABLE)  |   UBL CONJUGATION PATHWAY, LIGASE, STRUCTURAL GENOMICS, PSI, STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA CONSORTIUM, SGPP 
5dc9:A   (SER152) to   (VAL205)  CRYSTAL STRUCTURE OF MONOBODY AS25/ABL1 SH2 DOMAIN COMPLEX, CRYSTAL B  |   ENGINEERED BINDING PROTEIN, ANTIBODY MIMIC, PROTEIN-PROTEIN COMPLEX, SH2 DOMAIN, TYROSINE-PROTEIN KINASE, PROTEIN BINDING 
5dr3:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 333  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dr7:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 311  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4q1v:A    (THR80) to   (LYS137)  CRYSTAL STRUCTURE OF A PUTATIVE DIPEPTIDYL AMINOPEPTIDASE IV (BACOVA_01349) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.48 A RESOLUTION  |   TWO DOMAIN PROTEIN, DIPEPTIDYL-PEPTIDASE IV FAMILY (PF00930), PROLYL OLIGOPEPTIDASE FAMILY (PF00326), STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, HYDROLASE 
4q1v:B    (THR80) to   (LYS137)  CRYSTAL STRUCTURE OF A PUTATIVE DIPEPTIDYL AMINOPEPTIDASE IV (BACOVA_01349) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.48 A RESOLUTION  |   TWO DOMAIN PROTEIN, DIPEPTIDYL-PEPTIDASE IV FAMILY (PF00930), PROLYL OLIGOPEPTIDASE FAMILY (PF00326), STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, HYDROLASE 
5ehr:A    (THR12) to    (TYR66)  NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP099  |   PHOSPHATASE PTP INHIBITOR PTPN11 ALLOSTERIC, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5ehr:B    (THR12) to    (TYR66)  NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP099  |   PHOSPHATASE PTP INHIBITOR PTPN11 ALLOSTERIC, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5er2:E   (PRO224) to   (PRO269)  HIGH-RESOLUTION X-RAY DIFFRACTION STUDY OF THE COMPLEX BETWEEN ENDOTHIAPEPSIN AND AN OLIGOPEPTIDE INHIBITOR. THE ANALYSIS OF THE INHIBITOR BINDING AND DESCRIPTION OF THE RIGID BODY SHIFT IN THE ENZYME  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4bt4:A    (THR44) to    (GLU84)  ACETOLACTATE DECARBOXYLASE WITH A BOUND (2S,3S)-2,3- DIHYDROXY-2-METHYLBUTANOIC ACID  |   LYASE, ACETOIN BIOSYNTHESIS, STEREOSELECTIVE DECARBOXYLATION, BIFUNCTIONAL ENZYME 
3n4i:B    (THR96) to   (ASP163)  CRYSTAL STRUCTURE OF THE SHV-1 D104E BETA-LACTAMASE/BETA-LACTAMASE INHIBITOR PROTEIN (BLIP) COMPLEX  |   BETA-LACTAMASE, PROTEIN-PROTEIN COMPLEX, BLIP, SHV-1, HYDROLASE - HYDROLASE INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:H   (THR148) to   (LEU202)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:V   (THR148) to   (LEU202)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:j   (THR148) to   (LEU202)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r67:x   (THR148) to   (LEU202)  HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ra9:A   (ASP119) to   (ASN182)  CRYSTAL STRUCTURE OF CONJOINT PYROCOCCUS FURIOSUS L-ASPARAGINASE WITH CITRATE  |   HYDROLASE 
3d03:E   (HIS176) to   (PRO220)  1.9A STRUCTURE OF GLYCEROPHOSHPHODIESTERASE (GPDQ) FROM ENTEROBACTER AEROGENES  |   GLYCEROPHOSPHODIESTERASE, METALLOHYDROLASE, PHOSPHATASE, METAL ION, HYDROLASE 
4tr6:B   (PRO206) to   (ILE267)  CRYSTAL STRUCTURE OF DNA POLYMERASE SLIDING CLAMP FROM BACILLUS SUBTILIS  |   DNA POLYMERASE, SLIDING CLAMP, PROCESSIVITY, DNA BINDING PROTEIN 
4tr7:B   (PRO208) to   (MET276)  CRYSTAL STRUCTURE OF DNA POLYMERASE SLIDING CLAMP FROM MYCOBATERIUM TUBERCULOSIS  |   SLIDING CLAMP, PROCESSIVITY, DNA BINDING PROTEIN 
4dgp:A    (THR12) to    (TYR66)  THE WILD-TYPE SRC HOMOLOGY 2 (SH2)-DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2)  |   HYDROLASE 
4dgx:A   (SER118) to   (VAL181)  LEOPARD SYNDROME-ASSOCIATED SHP2/Y279C MUTANT  |   HYDROLASE 
3pjp:A  (GLY1263) to  (GLU1324)  A TANDEM SH2 DOMAIN IN TRANSCRIPTION ELONGATION FACTOR SPT6 BINDS THE PHOSPHORYLATED RNA POLYMERASE II C-TERMINAL REPEAT DOMAIN(CTD)  |   SH2, TRANSCRIPTION, TRANSCRIPTION ELONGATION, CTD BINDING, NUCLEUS 
3pjp:B  (GLY1263) to  (GLU1324)  A TANDEM SH2 DOMAIN IN TRANSCRIPTION ELONGATION FACTOR SPT6 BINDS THE PHOSPHORYLATED RNA POLYMERASE II C-TERMINAL REPEAT DOMAIN(CTD)  |   SH2, TRANSCRIPTION, TRANSCRIPTION ELONGATION, CTD BINDING, NUCLEUS 
3pll:A   (PRO228) to   (PRO274)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4fl3:A    (THR21) to    (ILE76)  STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH  |   TRANSFERASE, PROTEIN KINASE 
5ozj:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 30  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0a:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 57  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0w:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 79  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p13:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 86  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1c:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 95  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1o:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 107  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1t:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 112  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1v:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 114  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2s:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 145  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p39:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 162  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3a:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 163  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3f:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 168  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4n:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 212  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4u:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 219  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4x:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 222  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p50:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 225  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p51:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 226  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p52:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 227  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5b:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 236  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5p:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 250  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p60:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 261  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p67:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 268  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6b:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 272  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6f:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 276  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p73:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 300  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p74:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 301  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p79:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 306  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7f:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 312  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7g:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 313  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7h:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 314  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7k:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 317  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7l:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 318  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7s:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 325  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8g:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 349  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8i:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 351  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8q:A   (PRO228) to   (PRO274)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 359  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5t0g:J   (THR108) to   (GLY162)  STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME  |   UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE